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General. All reactions were carried out under Ar in flame-dried glassware unless H2O was used as a 
solvent. The solvents were purified by distillation over the drying agents indicated and were 
transferred under Ar: THF, Et2O (Mg/anthracene), CH2Cl2, hexane, toluene (Na/K), MeOH (Mg, 
stored over MS 3Å), EtOH (MS 3Å), EtOAc (P2O5, filter through dry Al2O3, store over 4Å MS); 
dioxane, DMF, MeCN , NEt3 and pyridine were dried by an adsorbtion solvent purification system 
based on molecular sieves. Thin layer chromatography (TLC): Macherey-Nagel precoated plates 
(POLYGRAM® SIL/UV254); Flash chromatography: Merck silica gel 60 (40–63 µm) with 
predistilled or HPLC grade solvents. NMR: Spectra were recorded on Bruker DPX 300, AV 400, AV 
500 or AVIII 600 spectrometer in the solvents indicated; chemical shifts (δ) are given in ppm relative 
to TMS, coupling constants (J) in Hz. The solvent signals were used as references and the chemical 
shifts converted to the TMS scale (CDCl3: δC 77.0 ppm; residual CHCl3 in CDCl3: δH 7.24 ppm; 
C6D6: δC128.0 ppm; residual C6D5H: δH7.16 ppm, pyr-d
5
: δC 150.35 ppm; residual CHCl3 in 
CDCl3: δH 7.24 ppm). IR: Spectrum One (Perkin-Elmer) spectrometer, wavenumbers (  ) in cm
1
. 
MS (EI): Finnigan MAT 8200 (70 eV), ESI-MS: ESQ3000 (Bruker), accurate mass determinations: 
Bruker APEX III FT-MS (7 T magnet) or Mat 95 (Finnigan). Optical rotations (     
 ) were measured 
with a Perkin-Elmer Model 343 polarimeter. Unless stated otherwise, all commercially available 
compounds (Alfa Aesar, Aldrich, Fluka, Lancaster) were used as received. 
 
(4S,6S)-Nona-1,8-diene-4,6-diol (4). According to the procedure from Krische et. al.,
1
 a flame-dried 
Young tube was charged with [Ir(cod)Cl]2 (974 mg, 1.45 mmol), (S)-Cl,MeO-
BIPHEP (1.89 g, 2.90 mmol), Cs2CO3 (3.78 g, 11.6 mmol) and 4-chloro-3-
nitrobenzoic acid (1.17 g, 5.80 mmol). 1,4-Dioxane (65 mL) and distilled allyl acetate (31.3 mL, 
290 mmol) were added, the flask was sealed, and the suspension heated to 90°C for 30 min and cooled 
back to room temperature. A solution of 1,3-propanediol (3) (2.10 mL, 29.0 mmol) in 1,4-dioxane 
(65 mL) was introduced, the flask sealed and stirring continued at 90°C for 72 h. After cooling to 
ambient temperature, the mixture was filtered through a pad of Celite (eluent: EtOAc) and the filtrate 
was concentrated. The brown residue was purified by flash chromatography (hexanes/EtOAc 3:1) to 
give the desired diol as a pale yellow oil (3.22 g, 71% yield, >99% ee, >29:1 d.r.).      
  = +24.5 (c = 
1.0, CHCl3). 
1
H NMR (400 MHz, CDCl3): δ = 5.85 – 5.72 (m, 2H), 5.13 – 5.09 (m, 2H), 5.09 – 5.07 
(m, 2H), 4.01 – 3.91 (br s, 2H), 2.72 – 2.57 (br s, 2H), 2.27 – 2.21 (m, 4H), 1.60 (tr, J = 5.8 Hz, 2H) 
ppm. 
13
C NMR (100 MHz, CDCl3): δ = 134.6, 118.0, 68.1, 42.0, 41.5 ppm. IR (film): ṽ = 3340, 3077, 
2979, 2936, 1723, 1641, 1434, 1327, 1232, 1133, 1047, 994, 912, 871, 830 cm
-1
. MS (EI) m/z (%) = 
115 (10), 97 (74), 79 (38), 73 (19), 71 (89), 69 (52), 67 (49), 55 (19), 45 (39), 41 (100), 39 (29), 29 
(13), 27 (28). HRMS (ESIpos): calcd for C9H16O2H: 157.1228; found: 157.1229. The enantiomeric 
excess was determined by HPLC analysis of the bis-(4-nitrobenzoate) derivative (5 eq. 4-nitro- 
                                                 
1
  Y. Lu, I. S. Kim, A. Hassan, D. J. Del Valle, M. J. Krische, Angew. Chem. Int. Ed. 2009, 48, 5018-5021. 
7 
benzoic acid anhydride, 10 eq. pyridine, 0.2 eq. DMAP, 0°C, 3h, CH2Cl2). HPLC: 250 mm Chiralpak 
IB (Ø 4.6 mm), n-heptane/2-propanol 85:15, 1.0 mL/min, 298 K, 4.4 MPa: Rt = 8.54 min (major), 

















(2S,4R,6S)-2-Allyl-6-(iodomethyl)tetrahydro-2H-pyran-4-ol (4a). NaHCO3 (4.18 g, 49.8 mmol) 
was added at 40°C to a solution of diol 4 (3.11 g, 19.9 mmol) in MeCN 
(360 mL) and the resulting suspension was vigorously stirred for 10 min. I2 
(15.2 g, 59.7 mmol) was carefully added in three portions and the resulting brown 
mixture stirred for 15 h at 40°C. The mixture was poured into sat. Na2S2O3-solution (200 mL) and 
rinsed with EtOAc (2 x 50 mL). After extraction with EtOAc (2 x 150 mL), the combined organic 
layers were dried over Na2SO4 and concentrated. The brown residue was purified by flash 
chromatography (hexanes/EtOAc 3:1) to yield a 5:1 mixture of diastereoisomers (based on 
1
H-NMR 
integration, solvent: C6D6) as a colorless oil (4.55 g, 81%). This mixture was purified by flash 
chromatography (SiO2 60 (15 x 40 µm), CH2Cl2/Et2O 5:1) to give the desired all-cis diastereomer as a 
colorless oil (3.54 g, 63%), which solidified upon prolonged storage at 20°C.      
  = +25.7 (c = 
0.37, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 5.84 (dddd, J = 16.8, 10.2, 7.5, 6.5 Hz, 1H), 5.11 – 
5.02 (m, 2H), 3.80 (m, 1H), 3.36 (m, 2H), 3.19 (dd, J = 5.8, 3.8 Hz, 2H), 2.42 – 2.30 (m, 1H), 2.26 – 
2.12 (m, 2H), 1.90 (ddt, J = 12.5, 4.3, 2.0 Hz, 1H), 1.63 (s, 1H), 1.14 (m, 2H) ppm. 
13
C NMR 
(100 MHz, CDCl3): δ = 134.3, 117.1, 75.4, 75.0, 67.8, 40.7, 40.2, 40.1, 8.7 ppm. IR (film): ṽ = 3346, 
2942, 2917, 2850, 1641, 1446, 1430, 1414, 1368, 1325, 1270, 1185, 1136, 1080, 1038, 998, 916, 854 
cm
-1
. MS (EI) m/z (%) = 282 (0.3), 241 (100), 223 (23), 197 (38), 73 (14), 67 (17), 45 (15), 43 (10). 
HRMS (ESIpos): calcd for C9H15O2INa: 305.0009; found: 305.0009.  
8 
(((2S,4R,6S)-2-allyl-6-(iodomethyl)tetrahydro-2H-pyran-4-yl)oxy)(tert-butyl)-dimethylsilane (5). 
A solution of alcohol 4a (3.10 g, 11.0 mmol) in CH2Cl2 (38 mL) was cooled to 
0°C before 2,6-lutidine (1.79 mL, 15.4 mmol) and TBSOTf (3.03 mL, 
13.2 mmol) were added dropwise via syringe. The mixture was stirred for 1 h at 
0°C before the reaction was quenched with sat. NH4Cl-solution (40 mL). After phase separation, the 
aqueous layer was extracted with EtOAc (2 x 25 mL), the combined organic layers were washed with 
brine (50 mL), dried over Na2SO4 and concentrated. The residue was purified by flash chromatography 
(hexanes/EtOAc 29:1) to yield the desired silyl ether as a colorless oil (4.18 g, 96%).      
  = +15.8 (c 
= 1.21, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 5.90 – 5.77 (m, 1H), 5.12 – 4.97 (m, 2H), 3.74 
(dddd, J = 10.8, 10.7, 4.8, 4.7 Hz, 1H), 3.35 – 3.24 (m, 2H), 3.16 (dd, J = 5.9, 1.5 Hz, 2H), 2.33 (dtt, J 
= 13.3, 6.6, 1.5 Hz, 1H), 2.18 (dddd, J = 14.4, 7.1, 5.7, 1.3 Hz, 1H), 2.00 (dddd, J = 12.4, 4.1, 1.9, 
1.8 Hz, 1H), 1.79 – 1.68 (m, 1H), 1.23 – 1.11 (m, 2H), 0.85 (s, 9H), 0.03 (s, 6H) ppm. 1H NMR 
(400 MHz, C6D6): δ = 5.92 (dddd, J = 16.7, 10.9, 8.3, 6.3 Hz, 1H), 5.09 – 4.98 (m, 2H), 3.54 (dddd, J 
= 10.8, 10.7, 4.9, 4.7 Hz, 1H), 3.07 (dddd, J = 11.5, 6.7, 5.1, 1.8 Hz, 1H), 2.93 (dddd, J = 11.2, 6.6, 
4.6, 2.0 Hz, 1H), 2.85 (dd, J = 10.1, 6.7 Hz, 1H), 2.76 (dd, J = 10.1, 4.6 Hz, 1H), 2.29 (dtt, J = 13.2, 
8.1, 6.6, 5.1 Hz, 1H), 2.08 (dddt, J = 14.0, 7.5, 5.2, 1.1 Hz, 1H), 1.74 (ddt, J = 12.3, 47, 2.0, 1H), 1.63 
(dddd, J = 12.6, 4.6, 2.0, 2.0 Hz, 1H), 1.21 (ddd, J = 12.6, 11.1, 11.1 Hz, 1H), 1.11 (ddd, J = 12.2, 
11.1, 11.0 Hz, 1H), 0.97 (s, 9H), 0.05 (s, 6H). ppm. 
13
C NMR (100 MHz, CDCl3): δ = 134.5, 116.8, 
75.4, 75.1, 68.3, 41.1, 40.7, 40.2, 25.8, 18.0, 8.9, 4.6 ppm. IR (film): ṽ = 2950, 2928, 2856, 1642, 
1471, 1462, 1383, 1251, 1126, 1087, 1068, 1005, 916, 833, 773, 669 cm
-1
. MS (EI) m/z (%) = 340 
(14), 339 (81), 271 (27), 269 (10), 172 (14), 171 (100), 141 (14), 129 (42), 101 (38), 79 (21), 75 (37), 
73 (23), 67 (11), 59 (14), 43 (25), 41 (18). HRMS (ESIpos): 
calcd for C15H29O2SiINa: 419.0872; found: 419.0874. 
 
At this stage, the relative stereochemistry of the 
tetrahydropyran ring was confirmed by NOESY experiments 
in C6D6 (which showed the best signal separation). Although 
no direct NOESY contacts between H5, H7 and H9 of the six-
membered ring were observed (which was the case on later 
intermediates, see for example the analysis of the final compounds 1 and 11-epi-1), the structure was 
assigned to an all-cis configured THP ring. Further evidence was obtained from the coupling constants 
in C6D6 for H6ax (1.21 ppm, ddd, J = 12.5, 11.3, 11.3 Hz) and H8ax (1.10 ppm, ddd, J = 12.2, 11.1, 
11.0 Hz), suggesting one geminal and two axial vicinal couplings; for H6eq (1.63 ppm, dddd, J = 12.6, 
4.6, 2.0, 2.0 Hz) and H8eq (1.74 ppm, dddd, J = 12.3, 4.4, 2.3, 2.3 Hz) one geminal and two equatorial 
vicinal coupling constants were observed. The coupling constants of H9 (2.93 ppm, dddd, J = 11.2, 
6.6, 4.6, 2.0 Hz) can be assigned to H8ax (11.2 Hz), H10a (6.6 Hz), H10b (4.6 Hz) and H8eq 
9 
(2.0 Hz), which is consistent with the assignment. The pseudosymmetric nature of the signals around 
the THP ring gives additional evidence for an all-cis substitution. 
 
(R)-3-((2R,4R,6S)-6-Allyl-4-((tert-butyldimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)-N-((1S,2S)-
1-Hydroxy-1-phenylpropan-2-yl)-N,2-dimethylpropanamide (7). A flame-dried 3-necked round-
bottom flask equipped with a stirbar, a reflux condenser and a 
dropping funnel was charged with dry LiCl (5.13 g, 121 mmol), 
diisopropylamine (6.24 mL, 44.4 mmol) and THF (75 mL). After 
cooling to 78°C, a solution of n-BuLi (1.50 M in hexanes, 29.0 mL, 
43.5 mmol) was added dropwise over 20 min and the mixture was 
stirred for 10 min before it was warmed to 0°C. After 10 min, the mixture was cooled to 78°C and a 
solution of (1S,2S)-N-(2-hydroxy-1-methyl-2-phenylethyl)-N-methylpropionic amide
2
 (6) (4.69 g, 
21.2 mmol) in THF (115 mL) was added over 45 min via the dropping funnel. The resulting yellow 
suspension was stirred for 1 h at 78°C, for 30 min at 0°C and for 20 min at RT before it was cooled 
to 0°C. A solution of alkyl iodide 5 (4.01 g, 10.1 mmol) in THF (6 mL + 2 x 2 mL rinse) was then 
added dropwise over 5 min via syringe. The mixture was warmed to 45°C and stirred at this 
temperature for 48 h. After cooling to RT, the reaction was quenched with sat. NH4Cl solution 
(300 mL) and the aqueous layer was extracted with EtOAc (4 x 200 mL). The combined extracts were 
dried over Na2SO4 and concentrated. The residue was purified by flash chromatography 
(hexanes/EtOAc 2:1) to give the alkylated compound as a white foam that collapsed to a colorless 
syrup upon storage (3.83 g, 76%).      




C NMR spectra were 
complex and broadened due to the presence of amide bond rotamers. IR (film): ṽ = 3387, 2933, 2930, 
2856, 1619, 1462, 1409, 1374, 1252, 1115, 1072, 913, 835, 774, 700, 673 cm
-1
. MS (EI) m/z (%) = 
433 (31), 432 (97), 383 (16), 382 (31), 325 (19), 258 (20), 257 (100), 216 (31), 193 (16), 171 (10), 148 
(21), 129 (10), 119 (11), 101 (12), 99 (19), 79 (11), 75 (22), 73 (25), 58 (39). HRMS (ESIpos): calcd 
for C28H47NO4SiNa: 512.3167; found: 512.3166. 
 
(S)-3-((2R,4R,6S)-6-Allyl-4-((tert-butyldimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)-N-((1R,2R)-




 (ent-6) and alkyl iodide 5 (3.08 g, 7.77 mmol) as a sticky 
syrup (3.20 g, 84%).      





NMR spectra were complex and partially broadened due to the 
presence of amide bond rotamers. IR (film): ṽ = 3376, 2934, 2930, 
2856, 1619, 1472, 1463, 1374, 1328, 1306, 1254, 1120, 1073, 1006, 915, 857, 836, 775, 702, 671 cm
-
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. MS (EI) m/z (%) = 474 (5), 433 (28), 432 (89), 383 (15), 382 (26), 325 (22), 258 (20), 257 (100), 
222 (17), 193 (13), 148 (18), 119 (10), 99 (19), 75 (15), 73 (17), 58 (23). HRMS (ESIpos): calcd for 
C28H47NO4SiNa: 512.3167; found: 512.3169. 
 
(R)-3-((2R,4R,6S)-6-allyl-4-((tert-Butyldimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)-2-methyl-
propan-1-ol (7a). A solution of n-BuLi (1.60 M in hexanes, 23.1 mL, 
37.0 mmol) was added over 15 min at 78°C to a solution of diisopropylamine 
(5.57 mL, 39.6 mmol) in THF (34 mL) and the resulting mixture was stirred at 
this temperature for 15 min and for 45 min at 0°C. Solid NH3·BH3 (90%, 1.31 g, 
38.1 mmol) was then added in one portion and the resulting mixture stirred for 
40 min at 0°C and for 45 min at ambient temperature. After cooling to 0°C, a solution of amide 7 
(3.80 g, 7.62 mmol) in THF (34 mL) was slowly added over 10 min. After stirring for 3 h at 0°C, the 
mixture was warmed to RT and stirring continued for 1 h before the reaction was quenched with sat. 
NH4Cl (200 mL) solution. The mixture was vigorously stirred for 45 min before the phases were 
separated, the aqueous phase was extracted with EtOAc (3 x 120 mL), the combined organic extracts 
were dried over Na2SO4 and concentrated. The residue was purified by flash chromatography 
(hexanes/EtOAc 5:1) to give the desired alcohol as a colorless oil (2.42 g, 96%).      
  = +17.8 (c = 
0.83, CH2Cl2). 
1
H NMR (400 MHz, C6D6): δ = 5.85 (dddd, J = 16.0, 9.2, 6.6, 6.6 Hz, 1H), 5.07 – 5.00 
(m, 2H), 3.63 (dddd, J = 10.7, 10.4, 5.1, 5.1 Hz, 1H), 3.46 (ddd, J = 10.5, 5.2, 5.1 Hz, 1H), 3.36 (ddd, 
J = 10.4, 5.1, 5.1 Hz, 1H), 3.19 – 3.04 (m, 2H), 2.26 (dddt, J = 14.1, 7.0, 7.0, 1.2 Hz, 1H), 2.22 – 2.15 
(br t, 1H), 2.12 – 2.04 (m, 1H), 1.78 (dddd, J = 12.4, 6.2, 6.2, 6.2 Hz, 1H), 1.75 – 1.61 (m, 2H), 1.55 
(ddd, J = 14.4, 9.6, 7.3 Hz, 1H), 1.34 – 1.21 (m, 2H), 1.09 (ddd, J = 14.4, 6.4, 2.3 Hz, 1H), 1.00 (s, 
9H), 0.87 (d, J = 6.8 Hz, 3H), 0.09 (s, 3H), 0.08 (s, 3H) ppm. 
13
C NMR (100 MHz, C6D6): δ = 134.9, 
117.2, 75.3, 74.8, 69.1, 68.2, 43.0, 41.4, 41.2, 40.8, 34.5, 26.0, 18.2, 18.0, 4.3 ppm. IR (film): ṽ = 
3395, 2926, 2929, 2856, 1643, 1472, 1462, 1375, 1253, 1152, 1123, 1070, 975, 914, 835, 774, 671 cm
-
1
. MS (EI) m/z (%) = 271 (33), 201 (20), 179 (37); 171 (47), 161 (16), 159 (47), 145 (46), 131 (12), 
129 (69), 127 (12), 125 (15), 119 (15), 111 (12), 109 (65), 107 (12), 105 (22), 101 (44), 93 (18), 85 
(93), 81 (28), 79 (26), 75 (100), 73 (49), 67 (43), 59 (22), 57 (14), 55 (24), 43 (17), 41 (32). HRMS 
(ESIpos): calcd for C18H36O3SiNa: 351.2326; found: 351.2326. 
 
(S)-3-((2R,4R,6S)-6-allyl-4-((tert-Butyldimethylsilyl)oxy)tetrahydro-2H-pyran-2-yl)-2-methyl-
propan-1-ol (11-epi-7a). Prepared analogously from amide 11-epi-7 (3.20 g, 
6.53 mmol) as a colorless oil (1.86 g, 87%).      
  = +1.8 (c = 1.03, CH2Cl2). 
1
H 
NMR (400 MHz, C6D6): δ = 5.85 (dddd, J = 17.7, 9.6, 7.0, 7.0 Hz, 1H), 5.08 – 
4.99 (m, 2H), 3.65 (dddd, J = 10.7, 10.7, 5.0, 4.8 Hz, 1H), 3.50 – 3.40 (m, 1H), 
3.36 (dd, J = 10.7, 6.6 Hz, 1H), 3.28 (dddd, J = 11.5, 8.3, 3.5, 1.9 Hz, 1H), 3.11 
(dddd, J = 11.4, 7.1, 5.3, 1.9 Hz, 1H), 2.25 (dtt, J = 14.0, 7.0, 1.4 Hz, 1H), 2.08 (dddd, J = 14.1, 8.6, 
11 
4.0, 2.6 Hz, 1H), 2.01 (br s, 1H), 1.86 (qt, J = 6.8, 5.3 Hz, 1H), 1.77 – 1.64 (m, 2H), 1.52 (ddd, J = 
13.9, 8.3, 5.4 Hz, 1H), 1.43 – 1.20 (m, 3H), 0.99 (s, 9H), 0.86 (d, J = 6.9 Hz, 3H), 0.08 (s, 6H) ppm. 
13
C NMR (100 MHz, C6D6): δ = 135.0, 117.0, 75.3, 73.5, 69.2, 67.5, 42.3, 41.6, 40.8, 40.0, 32.9, 26.0, 
18.2, 17.6, 4.3 ppm. IR (film): ṽ = 3394, 2950, 2929, 2857, 1375, 1254, 1151, 1123, 1072, 1005, 914, 
836, 775, 672 cm
-1
. MS (EI) m/z (%) = 271 (33), 201 (20), 179 (37); 171 (47), 161 (16), 159 (47), 145 
(46), 131 (12), 129 (69), 127 (12), 125 (15), 119 (15), 111 (12), 109 (65), 107 (12), 105 (22), 101 (44), 
95 (41), 93 (18), 85 (93), 81 (28), 79 (26), 75 (100), 73 (49), 67 (43), 59 (22), 57 (14), 55 (24), 43 
(17), 41 (32). HRMS (ESIpos): calcd for C18H36O3SiNa: 351.2326; found: 351.2327. 
 
Methyl (E)-4-((2S,4R,6R)-4-((tert-butyldimethylsilyl)oxy)-6-((R)-3-hydroxy-2-methylpropyl)-
tetrahydro-2H-pyran-2-yl)but-2-enoate (7b). Hoveyda-Grubbs 2
nd
 gen. 
catalyst 13 (137 mg, 0.219 mmol) was added to a solution of the terminal 
alkene 7a (2.40 g, 7.30 mmol) and methylacrylate (3.27 mmol, 36.5 mmol) in 
CH2Cl2 (70 mL). The mixture was stirred under Ar for 7.5 h at ambient 
temperature. After concentration, the residue (E/Z = 12:1 based on 
1
H NMR 
integration of a crude sample) was purified by flash chromatography (hexanes/EtOAc 5:1 to 4:1) to 
give the title compound as a pale brown oil (2.33 g, single isomer, 83%).      
  = +9.0 (c = 1.0, 
CH2Cl2). 
1
H NMR (400 MHz, C6D6): δ = 7.09 (dt, J = 15.6, 7.2 Hz, 1H), 5.90 (dt, J = 15.6, 1.5 Hz, 
1H), 3.57 (dddd, J = 10.8, 10.6, 4.9 4.8 Hz, 1H), 3.40 (s, 3H) 3.39 – 3.29 (m, 2H), 3.09 (dddd, J = 
11.7, 9.7, 2.3, 2.3 Hz, 1H), 2.96 (dddd, J = 11.7, 7.0, 4.7, 1.9 Hz, 1H), 2.09 (dddd, J = 14.8, 7.4, 7.3, 
1.5 Hz, 1H), 1.94 (dddd, J = 8.6, 8.6, 5.1, 2.0 Hz, 1H), 1.81 – 1.70 (m, 2H), 1.67 – 1.56 (m, 2H), 1.51 
(ddd, J = 14.4, 9.6, 6.9 Hz, 1H), 1.29 – 1.12 (m, 2H), 1.07 – 1.01 (m, 1H), 0.99 (s, 9H), 0.87 (d, J = 
6.8 Hz, 3H), 0.08 (s, 3H), 0.07 (s, 3H) ppm. 
13
C NMR (100 MHz, C6D6): δ = 166.4, 145.1, 123.5, 74.6, 
74.2, 68.9, 68.1, 51.0, 42.7, 41.5, 40.7, 38.7, 34.0, 26.0, 18.2, 17.7, 4.3, 4.3 ppm. IR (film): ṽ = 
3436, 2933, 2929, 2856, 1725, 1659, 1462, 1436, 1376, 1324, 1255, 1175, 1122, 1069, 985, 855, 836, 
775, 669 cm
-1
. MS (EI) m/z (%) = 329 (14), 237 (54), 229 (17), 203 (11), 159 (26), 137 (11), 131 (12), 
129 (20), 109 (30), 101 (23), 97 (20), 93 (21), 89 (11), 85 (100), 81 (15), 75 (46), 73 (32), 67 (18), 59 
(13), 55 (12), 41 (15). HRMS (ESIpos): calcd for C20H38O5SiNa: 409.2381; found: 409.2381. 
 
Methyl (E)-4-((2S,4R,6R)-4-((tert-butyldimethylsilyl)oxy)-6-((S)-3-hydroxy-2-methylpropyl)-
tetrahydro-2H-pyran-2-yl)but-2-enoate (11-epi-7b). Prepared analogously 
from the terminal alkene 11-epi-7a (1.82 g, 5.63 mmol) as a colorless oil 
(1.99 g, 91%).      
  = 0.4 (c = 1.09, CH2Cl2). 
1
H NMR (400 MHz, C6D6): δ 
= 7.09 (dt, J = 15.7, 7.1 Hz, 1H), 5.90 (dt, J = 15.7, 1.5 Hz, 1H), 3.59 (tt, J = 
10.5, 4.7 Hz, 1H), 3.40 (m, 5H), 3.27 – 3.15 (dddd, J = 11.6, 8.6, 3.4, 1.8 Hz, 
1H), 3.04 – 2.94 (dddd, J = 11.7, 7.4, 4.4, 2.1 Hz, 1H), 2.16 – 2.04 (m, 1H), 2.04 – 1.97 (br s, 1H), 
1.97 – 1.89 (dddd, J = 14.9, 7.1, 4.5, 1.5 Hz, 1H), 1.84 (tdd, J = 12.8, 7.3, 1.3 Hz, 1H), 1.67 (ddt, J = 
12 
12.6, 4.8, 1.9 Hz, 1H), 1.59 (ddt, J = 12.4, 4.8, 1.9 Hz, 1H), 1.43 (ddd, J = 14.1, 8.3, 5.7 Hz, 1H), 1.35 
(ddd, J = 14.2, 7.2, 3.9 Hz, 1H), 1.26 (ddd, J = 11.8, 11.6, 11.1 Hz, 1H), 1.19 (ddd, J = 11.7, 11.6, 
11.2 Hz, 1H), 0.98 (s, 9H), 0.87 (d, J = 6.9 Hz, 3H), 0.06 (s, 6H) ppm. 
13
C NMR (100 MHz, C6D6): δ 
= 166.6, 145.5, 123.3, 74.2, 73.8, 69.0, 67.5, 51.0, 42.2, 41.7, 40.0, 38.7, 32.9, 26.0, 18.2, 17.7, 4.3, 
4.3 ppm. IR (film): ṽ = 3436, 2951, 2930, 2857, 1726, 1660, 1463, 1436, 1376, 1330, 1256, 1175, 
1154, 1122, 1072, 987, 854, 837, 776 cm
-1
. MS (EI) m/z (%) = 329 (14), 237 (54), 229 (17), 203 (11), 
159 (26), 137 (11), 131 (12), 129 (20), 109 (30), 101 (23), 97 (20), 93 (21), 89 (11), 85 (100), 81 (15), 
75 (46), 73 (32), 67 (18), 59 (13), 55 (12), 41 (15). HRMS (ESIpos): calcd for C20H38O5SiNa: 
409.2381; found: 409.2382. 
 
(R)-Mosher Ester of (11-epi)-7b (all 4 possible Mosher Esters were prepared analogously): Pyridine 
(10.5 µL, 129 µmol) and (S)-(+)-α-methoxy-α-
trifluoromethylphenylacetyl chloride (9.77 µL, 51.8 µmol) were 
successively added to a solution of the primary alcohol 11-epi-7b 
(10.0 mg, 25.9 µmol) in CH2Cl2 (300 µL). The mixture was 
stirred for 90 min before the reaction was quenched by addition 
of NH4Cl-solution (3 mL). The aqueous phase was extracted with 
EtOAc (2 x 3 mL), the combined extracts were washed with 
NaHCO3-solution, dried over Na2SO4 and concentrated. The residue was purified by flash 
chromatography (hexanes/EtOAc 15:1) to give the desired (R)-mosher ester as a colorless oil 
(14.5 mg, 93%). 
1
H NMR (400 MHz, CDCl3): δ = 7.54 – 7.46 (m, 2H), 7.43 – 7.34 (m, 3H), 6.93 (dt, J 
= 15.6, 7.2 Hz, 1H), 5.84 (dt, J = 15.8, 1.4 Hz, 1H), 4.21 (dd, J = 10.8, 5.8 Hz, 1H), 4.13 (dd, J = 10.8, 
5.0 Hz, 1H), 3.70 (m, 4H), 3.52 (q, J = 1.2 Hz, 3H), 3.33 (dddd, J = 11.6, 7.0, 5.0, 1.9 Hz, 1H), 3.25 
(tdd, J = 9.2, 4.1, 2.0 Hz, 1H), 2.45 – 2.25 (m, 2H), 2.12 – 1.99 (m, 1H), 1.75 (ddt, J = 12.5, 4.1, 
1.8 Hz, 1H), 1.68 – 1.59 (m, 1H), 1.43 (ddd, J = 14.7, 8.8, 6.0 Hz, 1H), 1.34 (ddd, J = 14.2, 7.5, 
4.0 Hz, 1H), 1.14 (m, 2H), 0.94 (d, J = 6.8 Hz, 3H), 0.86 (s, 9H), 0.04 (s, 6H) ppm.
13
C NMR 
(100 MHz, CDCl3): δ = 166.8, 166.6, 145.4, 132.4, 129.6, 128.4, 127.4, 122.9, 74.1, 73.4, 70.5, 68.5, 
55.4, 51.4, 41.8, 41.2, 39.0, 38.7, 29.4, 25.8, 18.1, 17.6, 4.5, 4.5 ppm. 19F NMR (282 MHz, CDCl3): 
δ = 71.6 ppm. MS (ESIpos) m/z (%) = 625.4 (100 (M+Na+)). HRMS (ESIpos): calcd for 
C30H45F3O7SiNa: 625.2779; found: 625.2774. 
 
For a comparison of the full range 
1
H NMR spectra of all four diastereomers, see page 112; shown 





As expected from literature data,
3,4
 the distance between the two inner lines of the dd of the protons at 
C12 is bigger for the (R)-Mosher Ester of the (11R)-isomer, whereas it is bigger in case of the (S)-
Mosher Ester for the (11S)-isomer. Therefore the configuration of the stereogenic center at C11 







C11 H12a /ppm H12b /ppm 
(ppm) between 
two inner lines 
R R 4.24 (dd, J= 10.7, 5.2 Hz) 4.09 (dd, J= 10.7, 6.3 Hz) 0.108 
S R 4.19 (dd, J= 10.7, 5.3 Hz) 4.14 (dd, J= 10.7, 6.4 Hz) 0.009 
S S 4.21 (dd, J= 10.8, 5.3 Hz) 4.11 (dd, J= 10.8, 6.0 Hz) 0.058 
R S 4.21 (dd, J=10.8, 5.8 Hz) 4.13 (dd, J= 10.8, 5.0 Hz) 0.043 
 
  
                                                 
3
  E. Finamore, L. Minale, R. Riccio, G. Rinaldo, F. Zollo, J. Org. Chem. 1991, 56, 1146. 
4
  J. M. Seco, E. Quiñoá, R. Riguera, Chem. Rev. 2004, 104, 17 and references cited therein. 
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Methyl (E)-4-((2S,4R,6R)-4-((tert-butyldimethylsilyl)oxy)-6-((R)-2-methyl-3-oxopropyl)tetra-
hydro-2H-pyran-2-yl)but-2-enoate (8). A solution of Dess-Martin 
periodinane (524 mg, 1.24 mmol) in CH2Cl2 (2 mL) was cooled to 0°C 
before a solution of alcohol 7b (398 mg, 1.03 mmol) in CH2Cl2 (2 mL + 
1 mL rinse) was added dropwise via syringe. After 5 min, the mixture was 
allowed to warm to ambient temperature and stirring was continued for 3 h. 
The reaction was quenched by addition of aq. sat. Na2S2O3 and NaHCO3-solution (1:1, 15 mL) and the 
aqueous phase was extracted with CH2Cl2 (3x 10 mL). The combined organic layers were dried over 
Na2SO4 and concentrated, and the residue purified by flash chromatography (hexanes/EtOAc 12:1 to 
9:1) to yield the desired aldehyde as a colorless oil (305 mg, 77%).      
  = +3.4 (c = 0.81, hexane). 
1
H 
NMR (400 MHz, CDCl3): δ = 9.55 (d, J = 2.3 Hz, 1H), 6.91 (dd, J = 15.7, 7.3, 7.2 Hz, 1H), 5.83 (ddd, 
J = 15.7, 1.5, 1.5 Hz, 1H), 3.77 – 3.68 (m, 1H), 3.71 (s, 3H), 3.39 – 3.25 (m, 2H), 2.52 (dqd, J = 7.1, 
7.0, 2.4 Hz, 1H), 2.43 – 2.24 (m, 2H), 1.93 (ddd, J = 14.3, 9.9, 7.0 Hz, 1H), 1.80 – 1.71 (m, 2H), 1.38 
(ddd, J = 14.3, 7.1, 3.0 Hz, 1H), 1.26 – 1.14 (m, 2H), 1.06 (d, J = 7.0 Hz, 3H), 0.85 (s, 9H), 0.03 (s, 
6H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 204.8, 166.8, 145.2, 123.0, 74.2, 73.4, 68.4, 51.5, 43.8, 
41.8, 41.1, 38.6, 37.3, 25.8, 18.1, 13.8, 4.5 ppm. MS (EI) m/z (%) = 328 (15), 327 (60), 309 (27), 235 
(20), 229 (49), 227 (16), 203 (51), 201 (22), 199 (22), 185 (15), 183 (36), 175 (16), 157 (33), 145 (30), 
129 (33), 109 (15), 107 (23), 101 (48), 97 (29), 93 (29), 89 (22), 85 (31), 83 (25), 81 (36), 79 (15), 75 
(100), 73 (54), 59 (27), 41 (25). HRMS (ESIpos): calcd for C20H36O5SiNa: 407.2228; found: 407.2224. 
 
Methyl (E)-4-((2S,4R,6R)-4-((tert-butyldimethylsilyl)oxy)-6-((S)-2-methyl-3-oxopropyl)tetra-
hydro-2H-pyran-2-yl)but-2-enoate (11-epi-8). A slightly modified 
procedure had to be used: A solution of Dess-Martin periodinane (783 mg, 
1.85 mmol) in CH2Cl2 (2 mL) was cooled to 0°C and NaHCO3 (358 mg, 
4.27 mmol) was added as a solid, followed by addition of a solution of 
alcohol 11-epi-7b (550 mg, 1.42 mmol) in CH2Cl2 (2 mL + 1 mL rinse). 
After 5 min, the mixture was allowed to reach ambient temperature and stirring was continued for 3 h. 
The mixture was filtered and the filtrate loaded onto SiO2. Purification by flash chromatography 
(hexanes/EtOAc 12:1 to 9:1) gave the desired aldehyde as a colorless oil (414 mg, 76%).      
  = 
+17.7 (c = 1.105, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 9.59 (d, J = 1.4 Hz, 1H), 6.90 (dt, J = 
15.7, 7.2 Hz, 1H), 5.82 (dt, J = 15.7, 1.5 Hz, 1H), 3.71 (m, 4H), 3.39 – 3.26 (m, 2H), 2.61 – 2.48 (m, 
1H), 2.41 – 2.23 (m, 2H), 1.79 (ddd, J = 14.4, 8.1, 3.4 Hz, 1H), 1.77 – 1.70 (m, 2H), 1.65 (ddd, J = 
14.0, 9.2, 4.4 Hz, 1H), 1.24 – 1.12 (m, 2H), 1.08 (d, J = 7.2 Hz, 3H), 0.84 (s, 9H), 0.02 (s, 6H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 204.5, 166.8, 145.2, 122.9, 74.1, 72.8, 68.4, 51.4, 42.8, 41.6, 41.1, 
38.6, 36.9, 25.8, 18.0, 13.8, 4.5, 4.5 ppm. IR (film): ṽ = 2951, 2939, 2856, 1725, 1660, 1462, 1436, 
1376, 1330, 1255, 1175, 1122, 1072, 853, 776 cm
-1
. MS (EI) m/z (%) = 328 (14), 327 (60), 309 (29), 
235 (20), 229 (49), 227 (16), 203 (51), 201 (22), 199 (22), 185 (15), 183 (36), 175 (16), 157 (33), 155 
15 
(13), 153 (15), 151 (17), 145 (30), 143 (10), 129 (33), 109 (15), 107 (23), 101 (48), 97 (29), 93 (29), 
89 (22), 85 (31), 83 (25), 81 (36), 79 (15), 75 (100), 73 (54), 67 (17), 59 (27), 43 (17), 41 (25). HRMS 
(ESIpos): calcd for C20H36O5SiNa: 407.2224; found: 407.2224. 
 
Methyl (E)-4-((2S,4R,6R)-4-((tert-butyldimethylsilyl)oxy)-6-((R,E)-4-iodo-2-methylbut-3-en-1-yl)-
tetrahydro-2H-pyran-2-yl)but-2-enoate (9). A flame-dried Schlenk tube 
was charged with CrCl2·1.7 THF (1.21 g, 4.94 mmol) which was suspended 
in degassed THF (11.5 mL) and cooled to 8°C. Solid CHI3 (642 mg, 
1.63 mmol) was then added under vigorous stirring, causing a color change 
from green-grey to brown. After 5 min, a solution of aldehyde 8 (190 mg, 
0.494 mmol) in degassed THF (1 mL + 2 x 0.5 mL rinse) was added dropwise. After 3 h at 8°C, the 
reaction was quenched by addition of aq. serine/KHCO3 solution (1 M, pH = 8, 25 mL)
5
 and 
hexanes/EtOAc (1:1, 40 mL). The mixture was allowed to warm to room temperature and vigorously 
stirred for 30 min. After phase separation, the deep violet aqueous phase was extracted with 
hexanes/EtOAc (1:1, 3 x 40 mL) and the combined extracts were dried over Na2SO4 and concentrated. 
The residue was purified by flash chromatography (hexanes/EtOAc, 100:0 (until all CHI3 was 
removed) to 99:1 to 49:1 to 39:1 to 29:1) to yield the desired (E)-vinyl iodide as a colorless oil 
(181 mg, 72%) and the isomeric (Z)-vinyl-iodide (18.8 mg, 8%).      
  = 29.6 (c = 1.20, CH2Cl2). 
1
H 
NMR (400 MHz, CDCl3): δ = 6.94 (dt, J = 15.7, 7.2 Hz, 1H), 6.43 (dd, J = 14.4, 8.0 Hz, 1H), 5.95 (dd, 
J = 14.4, 1.0 Hz, 1H), 5.86 (dt, J = 15.7, 1.5 Hz, 1H), 3.76 – 3.66 (m, 1H), 3.71 (s, 3H), 3.41 – 3.30 
(m, 1H), 3.25 (dddd, J = 10.0, 8.4, 4.8, 1.8 Hz, 1H), 2.47 – 2.25 (m, 3H), 1.75 (m, 2H), 1.62 (ddd, J = 
13.8, 8.4, 6.5 Hz, 1H), 1.28 (ddd, J = 13.9, 7.0, 4.9 Hz, 1H), 1.25 – 1.09 (m, 2H), 0.97 (d, J = 6.7 Hz, 
3H), 0.86 (s, 9H), 0.03 (s, 6H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 166.9, 152.0, 145.4, 122.8, 
74.1, 73.3, 73.2, 68.6, 51.4, 41.9, 41.6, 41.3, 38.7, 37.1, 25.8, 19.1, 18.1, 4.5 ppm. IR (film): ṽ = 
2949, 2929, 2856, 1725, 1660, 1435, 1376, 1329, 1269, 1255, 1174, 1069, 950, 836, 775, 670 cm
-1
. 
MS (EI) m/z (%) = 452 (23), 451 (100), 229 (47), 197 (11), 181 (37), 169 (10), 157 (11), 131 (34), 129 
(31), 101 (19), 93 (12), 89 (13), 75 (28), 73 (21), 59 (11). HRMS (ESIpos): calcd for C21H37O4SiINa: 
531.1398; found: 531.1402. 
 
Methyl (E)-4-((2S,4R,6R)-4-((tert-butyldimethylsilyl)oxy)-6-((S,E)-4-iodo-2-methylbut-3-en-1-yl)-
tetrahydro-2H-pyran-2-yl)but-2-enoate (11-epi-9). Prepared analogously 
from aldehyde 11-epi-8 (404 mg, 1.05 mmol) as a mixture of olefin isomers 
(E/Z = 10:1). An aliquot (340 mg, 0.669 mmol) was purified by preparative 
HPLC (2 runs with 170 mg each, Nucleodur C18 HTec 10 µm, length: 250 
mm, Ø: 40 mm, MeOH/H2O =93:7, 75 mL/min) to give the desired (E)-
isomer as a colorless syrup (286 mg, 84%).      
  = +92.8 (c = 1. 01, CH2Cl2). 
1
H NMR (400 MHz, 
                                                 
5
  D. P. Stamos, X. C. Sheng, S. S. Chen, Y. Kishi, Tetrahedron Lett. 1997, 38, 6355. 
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CDCl3): δ = 6.95 (dt, J = 15.7, 7.1 Hz, 1H), 6.27 (dd, J = 14.3, 9.2 Hz, 1H), 6.00 (dd, J = 14.3, 0.7 Hz, 
1H), 5.86 (dt, J = 15.7, 1.5 Hz, 1H), 3.73 (m, 4H), 3.30 (dddd, J = 11.5, 8.2, 4.3, 1.9 Hz, 1H), 3.18 
(dddd, J = 12.0, 10.4, 3.1, 1.5 Hz, 1H), 2.49 (tdd, J = 9.2, 6.8, 3.9 Hz, 1H), 2.38 (dddd, J = 15.3, 8.4, 
7.1, 1.5 Hz, 1H), 2.29 (dddd, J = 9.1, 7.1, 3.6, 1.4 Hz, 1H), 1.80 – 1.64 (m, 2H), 1.50 (ddd, J = 14.2, 
10.2, 4.2 Hz, 1H), 1.29 – 1.11 (m, 3H), 0.97 (d, J = 6.8 Hz, 3H), 0.85 (s, 9H), 0.03 (s, 6H) ppm. 13C 
NMR (100 MHz, CDCl3): δ = 166.8, 151.2, 145.9, 122.6, 74.4, 74.3, 73.2, 68.5, 51.5, 42.4, 41.9, 41.5, 
38.6, 37.4, 25.8, 20.6, 18.1, 4.5, 4.5 ppm. IR (film): ṽ = 2950, 2928, 2855, 1724, 1660, 1435, 1375, 
3129, 1253, 1219, 1175, 1156, 1126, 1067, 987, 955, 869, 834, 774, 669 cm
-1
. MS (EI) m/z (%) = 452 
(24), 451 (100), 229 (41), 181 (22), 131 (26), 129 (20), 101 (11), 75 (14), 73 (10). HRMS (ESIpos): 
calcd for C21H37O4SiINa: 531.1398; found: 531.1393.  
 
Methyl (E)-4-((2S,4R,6R)-4-((tert-butyldimethylsilyl)oxy)-6-((R,E)-2-methylhept-3-en-5-yn-1-yl)-
tetrahydro-2H-pyran-2-yl)but-2-enoate (10). A flame-dried two-
necked round-bottom flask equipped with a reflux condenser was 
charged with 1-propynylsodium (42.1 mg, 0.677 mmol), which was 
suspended in degassed THF (4 mL). Trimethyl borate (76.9 µL, 
0.677 mmol) was added dropwise via syringe at RT. After stirring for 
20 min, [Pd(dppf)Cl2]·CH2Cl2 (42.5 mg, 0.0521 mmol) was added, 
causing the reaction mixture to turn dark red. Next, a solution of (E)-vinyl iodide 9 (265 mg, 
0.521 mmol) in degassed THF (3 mL + 1 mL rinse) was added and the mixture stirred at 65°C. After 
2 h, the pale orange mixture was allowed to cool to ambient temperature, the reaction was quenched 
with sat. NH4Cl/H2O (1:1 v/v, 15 mL), the organic phase was extracted with EtOAc (3x 20 mL) and 
the combined extracts were dried over Na2SO4 and concentrated. The crude product was purified by 
flash chromatography (hexanes/EtOAc 49:1 to 39:1 to 29:1) to give the title compound as a pale 
yellow oil (177 mg, 81%).      
  = 30.0 (c = 0.92, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 6.94 
(dt, J = 15.7, 7.2 Hz, 1H), 5.93 (ddd, J = 15.9, 7.9, 0.8 Hz, 1H), 5.85 (dt, J = 15.7, 1.5 Hz, 1H), 5.37 
(dqd, J = 15.9, 2.2, 1.1 Hz, 1H), 3.76 – 3.66 (m, 1H), 3.71 (s, 3H), 3.39 – 3.30 (m, 1H), 3.25 (dddd, J 
= 11.2, 7.4, 5.5, 1.7 Hz, 1H), 2.47 – 2.25 (m, 3H), 1.90 (d, J = 2.2 Hz, 3H), 1.75 (dt, J = 4.8, 1.5 Hz, 
1H), 1.75 (dt, J = 4.8, 1.5 Hz, 1H), 1.61 (dddd, J = 7.1, 7.1, 7.0, 6.9 Hz, 1H), 1.28 (ddd, J = 13.6, 7.7, 
5.7 Hz, 1H), 1.24 – 1.09 (m, 2H), 0.96 (d, J = 6.7 Hz, 3H), 0.86 (s, 9H), 0.03 (s, 6H) ppm. 13C NMR 
(100 MHz, CDCl3): δ = 166.9, 148.5, 145.5, 122.8, 108.2, 84.4, 78.3, 74.1, 73.2, 68.6, 51.4, 42.3, 41.5, 
41.3, 38.7, 33.4, 25.8, 19.6, 18.1, 4.2, 4.5, 4.5 ppm. IR (film): ṽ = 2951, 2928, 2856, 1725, 1660, 
1435, 1376, 1328, 1255, 1174, 1068, 985, 962, 836, 775, 670 cm
-1
. MS (EI) m/z (%) = 420 (19), 364 
(11), 363 (40), 313 (13), 288 (11), 229 (53), 189 (17), 181 (37), 171 (12), 169 (13), 159 (16), 157 (14), 
145 (32), 131 (24), 129 (37), 123 (10), 121 (10), 120 (13), 119 (37), 108 (13), 105 (23), 101 (33), 97 
(18), 93 (100), 91 (45), 89 (21), 81 (19), 79 (13), 77 (41), 75( 48), 73 (46), 59 (17), 41 (14). HRMS 




tetrahydro-2H-pyran-2-yl)but-2-enoate (11-epi-10). Prepared 
analogously from vinyl iodide 11-epi-9 (185 mg, 1.05 mmol) as a pale 
yellow oil (117 mg, 76%).      
  = +93.8 (c = 0.99, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ = 6.96 (dt, J = 15.7, 7.1 Hz, 1H), 5.86 (dt, J = 
15.8, 1.5 Hz, 1H), 5.79 (ddd, J = 15.8, 9.0, 0.8 Hz, 1H), 5.41 (dqd, J = 
15.9, 2.3, 0.8 Hz, 1H), 3.72 (m, 4H), 3.38 – 3.25 (m, 1H), 3.20 (dddd, 
J = 11.8, 10.2, 3.0, 1.9 Hz, 1H), 2.53 – 2.34 (m, 2H), 2.30 (tdd, J = 7.7, 4.6, 1.6 Hz, 1H), 1.91 (d, J = 
2.3 Hz, 3H), 1.79 – 1.70 (m, 1H), 1.71 – 1.63 (m, 1H), 1.53 (ddd, J = 14.0, 10.1, 4.0 Hz, 1H), 1.28 – 
1.10 (m, 3H), 0.96 (d, J = 6.8 Hz, 3H), 0.85 (s, 9H), 0.02 (s, 6H) ppm. 
13
C NMR (100 MHz, CDCl3): δ 
= 166.8, 148.0, 145.8, 122.7, 109.2, 84.2, 78.4, 74.1, 73.3, 68.6, 51.4, 42.9, 42.0, 41.4, 38.6, 33.9, 
25.8, 21.1, 18.1, 4.2, 4.5, 4.6 ppm. IR (film): ṽ = 2951, 2929, 2856, 1727, 1660, 1435, 1375, 1329, 
1257, 1218, 1155, 1118, 1072, 962, 852, 837, 776 cm
-1
. MS (EI) m/z (%) = 420 (19), 364 (11), 363 
(40), 313 (13), 288 (11), 229 (53), 189 (17), 181 (37), 171 (12), 169 (13), 159 (16), 157 (14), 145 (32), 
131 (24), 129 (37), 123 (10), 121 (10), 120 (13), 119 (37), 107 (13), 105 (23), 101 (33), 97 (18), 93 
(100), 91 (45), 89 (21), 81 (19), 79 (14), 77 (41), 75( 48), 73 (46), 59 (17), 41 (14). HRMS (ESIpos): 
calcd for C24H40O4SiNa: 443.2588; found: 443.2586. 
 
(E)-4-((2S,4R,6R)-4-((tert-Butyldimethylsilyl)oxy)-6-((R,E)-2-methylhept-3-en-5-yn-1-yl)tetra-
hydro-2H-pyran-2-yl)but-2-enoic acid (11). KOTMS (90%, 246 mg, 
1.73 mmol) was added to a solution of methyl ester 10 (145 mg, 
0.345 mmol) in Et2O (7.0 mL). After stirring for 1h, additional KOTMS 
(90%, 246 mg, 1.73 mmol) was introduced and stirring of the yellow 
suspension continued for 5 h. Excess base was quenched with aq. HCl 
(0.5 M, 10 mL) and the aqueous layer was extracted with EtOAc (5 x 
15 mL). The combined organic phases were dried over Na2SO4 and concentrated, and the residue 
purified by flash chromatography (hexanes/EtOAc 6:1 with 0.1% AcOH) to give the desired acid as a 
colorless oil (112 mg, 80%). As a by-product, the β,γ-olefin was isolated as a colorless oil (9.8 mg, 
7%).      
  = 28.2 (c = 1.37, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 13.0 – 10.4 (br s, 1H), 7.06 
(dt, J = 15.7, 7.1 Hz, 1H), 5.93 (dd, J = 15.9, 7.8 Hz, 1H), 5.84 (dt, J = 15.7, 1.2 Hz, 1H), 5.37 (ddd, J 
= 15.9, 2.1, 1.1 Hz, 1H), 3.72 (m, 1H), 3.43 – 3.31 (m, 1H), 3.31 – 3.19 (m, 1H), 2.51 – 2.28 (m, 3H), 
1.90 (d, J = 2.3 Hz, 3H), 1.80 – 1.73 (m, 2H), 1.61 (dddd, J = 7.1, 7.0, 7.0, 6.9 Hz, 1H), 1.29 (ddd, J = 
13.6, 7.7, 5.7 Hz, 1H), 1.25 – 1.08 (m, 2H), 0.97 (d, J = 6.7 Hz, 3H), 0.86 (s, 9H), 0.04 (s, 6H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 171.4, 148.5, 148.2, 122.4, 108.2, 84.4, 78.3, 73.9, 73.3, 68.6, 42.3, 
41.5, 41.4, 38.8, 33.4, 25.8, 19.6, 18.1, 4.2, 4.5, 4.5 ppm. IR (film): ṽ = 2928, 2926, 2855, 1698, 
1654, 1462, 1443, 1376, 1282, 1255, 1152, 1068, 960, 852, 835, 815, 774, 699, 669 cm
-1
. MS (EI) m/z 
18 
(%) = 418 (5), 349 (8), 257 (13), 237 (24), 169 (23), 160 (12), 145 (27), 131 (33), 129 (11), 121 (10), 
119 (28), 107 (12), 105 (12), 101 (24), 93 (100), 91 (37), 79 (13), 77 (37), 75 (47), 73 (32), 59 (11), 41 
(11). HRMS (ESIpos): calcd for C23H38O4SiNa: 429.2427; found: 429.2431.  
 
(E)-4-((2S,4R,6R)-4-((tert-butyldimethylsilyl)oxy)-6-((S,E)-2-methylhept-3-en-5-yn-1-yl)tetra-
hydro-2H-pyran-2-yl)but-2-enoic acid (11-epi-11). Prepared 
analogously from methyl ester 11-epi-10 (116 mg, 0.276 mmol) as a 
colorless oil (101 mg, 88%), along with the corresponding β,γ-olefin as 
a colorless oil (8.2 mg, 7%).      
  = +84.0 (c = 1.02, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ = 13.6 – 9.40 (br s, 1H), 7.08 (dt, J = 15.8, 7.0 Hz, 
1H), 5.87 (d, J = 15.7 Hz, 1H), 5.79 (ddd, J = 15.9, 8.9, 0.9 Hz, 1H), 
5.41 (ddt, J = 16.0, 2.7, 1.9 Hz, 1H), 3.79 – 3.63 (m, 1H), 3.34 (dddd, J = 12.6, 6.1, 4.0, 1.7 Hz, 1H), 
3.22 (dddd, J = 10.9, 10.4, 2.1, 1.8 Hz, 1H), 2.53 – 2.37 (m, 2H), 2.34 (m, 1H), 1.90 (dd, J = 2.3, 
0.7 Hz, 3H), 1.81 – 1.63 (m, 2H), 1.53 (ddd, J = 14.1, 10.0, 4.1 Hz, 1H), 1.30 – 1.10 (m, 3H), 0.96 (d, 
J = 6.8 Hz, 3H), 0.85 (s, 9H), 0.02 (s, 6H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 171.5, 148.3, 148.0, 
122.4, 109.2, 84.3, 78.4, 74.0, 73.4, 68.5, 42.9, 41.9, 41.5, 38.7, 33.9, 25.8, 21.1, 18.1, 4.2, 4.5, 4.6 
ppm. IR (film): ṽ = 2952, 2928, 2856, 1696, 1653, 1421, 1375, 1304, 1283, 1254, 1154, 1117, 976, 
960, 924, 852, 834, 774, 739, 669 cm
-1
. MS (EI) m/z (%) = 418 (6), 349 (8), 257 (13), 237 (25), 169 
(23), 160 (12), 145 (27), 131 (33), 129 (11), 121 (10), 119 (28), 107 (12), 105 (11), 101 (24), 93 (100), 
91 (39), 79 (13), 77 (37), 75 (49), 73 (32), 59 (12). HRMS (ESIneg): calcd for C23H37O4Si: 405.2467; 
found: 405.2468. 
 
(R)-tert-Butyl(oxiran-2-ylmethoxy)diphenylsilane (16). A solution of TBDPSCl (18.1 mL, 
69.4 mmol) in CH2Cl2 (50 mL) was added over 15 min via a dropping funnel to a 
solution of (S)-glycidol (15) (4.41 mL, 66.1 mmol) and imidazole (5.99 g, 
87.9 mmol) in CH2Cl2 (200 mL) at 0°C. A white solid started to precipitate after 5 min and the 
reaction mixture was allowed to warm to RT. After 2 h, H2O (250 mL) was added and the aqueous 
phase extracted with CH2Cl2 (2 x 100 mL). The combined organic layers were washed with brine, 
dried over Na2SO4 and concentrated. The residue was purified by flash chromatography 
(hexanes/EtOAc 19:1 to 9:1) to give the desired silyl ether as a colorless oil (19.5 g, 94%).      
  = 
+0.9 (c = 1.41, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 7.75 – 7.61 (m, 4H), 7.47 – 7.32 (m, 6H), 
3.84 (dd, J = 11.8, 3.2 Hz, 1H), 3.70 (dd, J = 11.8, 4.7 Hz, 1H), 3.14 – 3.09 (m, 1H), 2.73 (dd, J = 5.2, 
4.0 Hz, 1H), 2.60 (dd, J = 5.2, 2.7 Hz, 1H), 1.05 (s, 9H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 135.6, 
135.5, 132.3, 129.7, 127.0, 64.3, 52.3, 44.4, 26.8, 19.2 ppm. IR (film): ṽ = 3071, 3049, 2998, 2930, 
2894, 2857, 1472, 1427, 1390, 1361, 1254, 1159, 1136, 1111, 1091, 1030, 980, 917, 823, 739, 700, 
690 cm
-1
. MS (EI) m/z (%) = 256 (11), 255 (53), 226 (20), 225 (100), 211 (22), 184 (16), 183 (87), 
19 




According to a modified protocol from Jacobsen et. al.,
6
 a flame-dried 
two-necked round-bottom flask was charged with Co2(CO)8 (274 mg, 




 and backfilled with 
CO (1 atm, from a balloon, 3 cycles). Dry EtOAc (15 mL) was introduced and the suspension stirred 
for 10 min, at which point freshly distilled N-trimethylsilyl morpholine (2.66 mL, 15.0 mmol) and 
silylated epoxide 16 (3.12 g, 10.0 mmol) were added via syringe. The brown mixture was vigorously 
stirred under CO atmosphere (balloon) for 15 h, before it was concentrated. The residue was quickly 
purified by flash chromatography (hexanes/EtOAc 5:1 to 4:1) to yield the desired morpholine amide as 
a colorless oil (3.70 g, 74%).      
  = +21.1 (c = 0.915, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 
7.65 (m, 4H), 7.43 – 7.34 (m, 6H), 4.25 (ddt, J = 8.5, 5.9, 4.3 Hz, 1H), 3.63 (m, 7H), 3.56 – 3.44 (m, 
3H), 2.62 (dd, J = 14.4, 4.0 Hz, 1H), 2.53 (dd, J = 14.4, 8.3 Hz, 1H), 1.04 (s, 9H), 0.02 (s, 9H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 170.1, 135.6, 135.6, 133.4, 129.7, 129.7, 127.7, 127.7, 70.7, 67.8, 
66.9, 66.7, 46.5, 41.9, 37.5, 26.8, 26.8, 19.2, 0.1 ppm. IR (film): ṽ = 2958, 2930, 2857, 1644, 1460, 
1428, 1249, 1186, 1111, 1070, 1033, 959, 840, 824, 741, 701, 612 cm
-1
. MS (EI) m/z (%) = 484 (11), 
444 (13), 443 (36), 442 (100), 364 (23), 271 (13), 230 (6), 193 (14), 135 (5), 114 (7), 73 (4). HRMS 
(ESIpos): calcd for C27H41NO4Si2Na: 522.2466; found: 522.2465. 
 
(R)-7-((tert-Butyldiphenylsilyl)oxy)-6-hydroxyhept-2-en-4-one (19). A solution of 
propenylmagnesium bromide (18) (0.5 M in THF, 8.6 mL, 4.30 mmol) was 
added dropwise over 10 min at 0°C to a solution of amide 17 (565 mg, 
1.131 mmol) in THF (9 mL) and the resulting mixture was stirred at 0°C for 
2 h. The mixture was cooled to 78°C and slowly transferred via canula into a vigorously stirred aq. 
solution of HCl (0.75 M, 130 mL). The reaction flask was rinsed with EtOAc (2 x 10 mL), which was 
also transferred to the aqueous acid layer. After stirring for 15 min at ambient temperature, EtOAc 
(20 mL) was added, the phases were separated and the aqueous phase extracted with EtOAc (3 x 
40 mL). The combined organic layers were washed with brine (50 mL), dried over Na2SO4 and 
concentrated. The residue was purified by flash chromatography (hexanes/EtOAc 9:1 to 7.5:1 to 6:1) 
to give the desired enone as an inconsequential mixture of olefin isomers (E/Z = 2:1, 360 mg, 83%). 
1
H NMR (300 MHz, CDCl3, only the peaks assigned to the major isomer are given): δ = 7.70 – 7.57 
(m, 4H), 7.47 – 7.31 (m, 6H), 6.84 (dq, J = 15.7, 6.8 Hz, 1H), 6.11 (dq, J = 15.8, 1.6 Hz, 1H), 4.25 – 
4.14 (m, 1H), 3.65 (d, J = 5.5 Hz, 2H), 3.02 (d, J = 4.1 Hz, 1H), 2.72 (d, J = 5.9 Hz, 2H), 1.89 (dd, J = 
                                                 
6
  S. N. Goodman, E. N. Jacobsen, Angew. Chem. Int. Ed. 2002, 41, 4703-4705. 
7
  Due to the volatility of the catalyst, a higher vacuum should be avoided. 
20 
6.9, 1.7 Hz, 3H), 1.05 (s, 9H) ppm. 
13
C NMR (100 MHz, CDCl3 only the peaks assigned to the major 
isomer are given): δ = 199.6, 143.7, 135.5, 135.5, 133.2, 133.1, 132.3, 129.8, 127.7, 68.5, 67.0, 42.8, 
26.8, 19.2, 18.3 ppm. IR (film): ṽ = 3462, 3071, 2930, 2587, 1680, 1663, 1628, 1472, 1428, 1362, 
1188, 1112, 969, 823, 741, 702 cm
-1
. MS (ESIpos) m/z (%) = 405.2 (100 (M+Na
+
)), 787.3 (85 
((2M+Na
+
). HRMS (ESIpos): calcd for C23H30O3SiNa: 405.1856; found: 405.1856. 
 
3-(Benzyloxy)propanal (21). According to the procedure of Stahl et. al.,
8
 a 1 L-round-bottom flask 
was charged with 3-(benzyloxy)propanol (20) (7.20 g, 43.3 mmol) and MeCN (HPLC 
grade, 210 mL). [Cu(MeCN)4]BF4 (683 mg, 2.17 mmol) and 2,2’-bipyridine (339 mg, 
2.17 mmol) were added as solids, followed by N-methyl imidazole (346 µL, 4.34 mmol) and TEMPO 
(339 mg, 2.17 mmol). The resulting red/brown mixture was vigorously stirred open to air for 3 h until 
the reaction mixture turned dark green. After concentration at reduced pressure, the residue was 
purified by flash chromatography (hexanes/EtOAc 6:1 to 5:1 to 4:1) to give the desired aldehyde as a 
colorless oil with an unpleasant smell (6.69 g, 94%). 
1
H NMR (400 MHz, CDCl3): δ = 9.78 (t, J = 
1.8 Hz, 1H), 7.41 – 7.22 (m, 5H), 4.52 (s, 2H), 3.80 (td, J = 6.1, 1.2 Hz, 2H), 2.68 (tt, J = 6.1, 1.6 Hz, 
2H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 201.1, 137.8, 128.4, 127.7, 127.7, 73.2, 63.8, 43.9 ppm. 
IR (film): ṽ = 3031, 2860, 2733, 1721, 1496, 1454, 1394, 1362, 1205, 1091, 1027, 899, 885, 736, 697 
cm
-1
. MS (EI) m/z (%) = 108 (79), 107 (85), 92 (17), 91 (66), 79 (100), 78 (14), 77 (56), 65 (14), 56 
(29), 55 (22), 51 (18), 39 (10), 28 (11), 27 (22), 26 (11). HRMS (ESIpos): calcd for C10H12O2H: 
165.0916; found: 165.0914. 
 
(3R,4R)-1-(Benzyloxy)-4-methylhex-5-en-3-ol (22). A solution of crotylsilane (R,R)-31
9
 (1.0 M in 
CH2Cl2, 6.62 mmol, 6.62 mL) was added dropwise at 78°C
10
 via syringe to a 
solution of aldehyde 21 (906 mg, 5.52 mmol) in CH2Cl2 (56 mL). Next, solid 
Sc(OTf)3 (136 mg, 0.276 mmol) was added and the mixture stirred for 15 min at 
78°C before it was allowed to reach 0°C. Stirring was continued for 2 h. At this point, NMR analysis 
of an aliquot (50 µL) confirmed full consumption of the aldehyde. The mixture was concentrated and 
treated with HCl (1 M, 70 mL) and Et2O (70 mL) under vigorous stirring for 1 h. The white precipitate 
was filtered off and washed with Et2O (2 x 10 mL) (treatment of this solid with NaOH allowed the 
diamine ligand to be recovered after chromatographic purification in > 90%). The phases of the filtrate 
were separated and the aqueous layer extracted with Et2O (3 x 50 mL). The combined extracts were 
washed with NaHCO3 (70 mL), dried over Na2SO4, and concentrated. The residue was purified by 
flash chromatography (hexanes/EtOAc 5:1) to give the crotylated alcohol as a colorless oil (995 mg, 
82% yield, 94% ee, 98:2 d.r.).      
  = +16.5 (c = 1.18, CHCl3). 
1
H NMR (400 MHz, CDCl3): δ = 7.40 
                                                 
8
  J. M. Hoover, S. S. Stahl, J. Am. Chem. Soc. 2011, 133, 16901-16910. 
9
  B. Hackman, P. J. Lombardi, J. L. Leighton, Org. Lett. 2004, 6, 4375. 
10
  If the addition of Sc(OTf)3 was performed at 0°C as described in the literature, lower ee values were 
obtained. 
21 
– 7.25 (m, 5H), 5.77 (ddd, J = 17.7, 10.4, 7.6 Hz, 1H), 5.09 – 4.98 (m, 2H), 4.50 (s, 2H), 3.75 – 3.59 
(m, 3H), 2.80 (br s, 1H), 2.25 (m, 1H), 1.82 – 1.62 (m, 2H), 1.03 (d, J = 6.8 Hz, 3H) ppm. 13C NMR 
(100 MHz, CDCl3): δ = 141.0, 137.9, 128.4, 127.7, 127.7, 114.9, 74.5, 73.3, 69.4, 43.9, 33.5, 15.0 
ppm. IR (film): ṽ = 3471, 3031, 2943, 2865, 1638, 1496, 1454, 1418, 1363, 1206, 1092, 1071, 1028, 
997, 949, 913, 736, 697 cm
-1
. MS (EI) m/z (%) = 220 (0.1), 165 (2.6), 107 (14), 92 (13), 91 (100), 79 
(7), 65 (8), 55 (7). HRMS (ESIpos): calcd for C14H20O2Na: 243.1355; found: 243.1356. The 
enantiomeric excess was determined by HPLC of the TBS ether (prepared from the alcohol with 
TBSOTf (1.2 eq.) and 2,6-lutidine (1.4 eq.) in CH2Cl2): HPLC: 150 mm Chiralcel OJ-3R (Ø 4.6 mm), 
MeCN/water 70:30, 0.5 mL/min, 308 K, 9.2 MPa: Rt = 12.64 min (major syn), 14.10 min (anti), 




(((3R,4R)-1-(Benzyloxy)-4-methylhex-5-en-3-yl)oxy)triethylsilane (23). NEt3 (0.951 mL, 
6.86 mmol) and TESCl (1.05 mL, 6.29 mmol) were added via syringe at 0°C to a 
solution of alcohol 22 (1.26 g, 5.72 mmol) in CH2Cl2 (28.6 mL). DMAP (34.9 mg, 
0.286 mmol) was then introduced and the mixture stirred for 90 min at 0°C and for 
another 30 min at RT before the reaction was quenched with sat. NH4Cl-solution. The aqueous phase 
was extracted with CH2Cl2 (3 x 30 mL), the combined extracts were washed with brine, dried over 
Na2SO4 and concentrated. Purification of the residue by flash chromatography (hexanes/EtOAc 35:1) 
yielded the target silyl ether as a colorless oil (1.72 g, 90%).      
  = +38.6 (c = 1.13, CH2Cl2). 
1
H 
NMR (400 MHz, CDCl3): δ = 7.39 – 7.24 (m, 5H), 5.86 (ddd, J = 17.3, 10.5, 6.6 Hz, 1H), 5.03 – 4.95 
(m, 2H), 4.50 (d, J = 11.6 Hz, 1H), 4.45 (d, J = 11.8 Hz, 1H), 3.74 (dt, J = 8.2, 4.3, 4.2 Hz, 1H), 3.53 
(t, J = 6.7 Hz, 2H), 2.35 – 2.22 (m, 1H), 1.83 – 1.70 (m, 1H), 1.70 – 1.59 (m, 1H), 0.97 (d, J = 6.8 Hz, 
3H), 0.94 (dd, J = 7.7 Hz, 9H), 0.58 (q, J = 8.0 Hz, 6H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 140.8, 
138.6, 128.3, 127.7, 127.5, 114.3, 73.2, 73.0, 67.2, 43.4, 33.7, 15.0, 7.0, 5.2 ppm. IR (film): ṽ = 2954, 
2911, 2876, 1455, 1414, 1363, 1238, 1091, 1004, 911, 840, 725, 695 cm
-1
. MS (EI) m/z (%) = 305 (8), 
22 
279 (17), 173 (33), 159 (6), 117 (9), 115 (10), 91 (100), 87 (9), 59 (5). HRMS (ESIpos): calcd for 
C20H34O2SiNa: 357.2220; found: 357.2222. 
 
(6R,11R,12R,E)-12-(2-(Benzyloxy)ethyl)-14,14-diethyl-6-hydroxy-2,2,11-trimethyl-3,3-diphenyl-
4,13-dioxa-3,14-disilahexadec-9-en-8-one (24). A flame-dried 
two necked round-bottom flask equipped with a reflux 
condenser and a septum was charged with a solution of olefin 
23 (495 mg, 1.48 mmol) in CH2Cl2 (15 mL). The Zhan-catalyst 
1B 32 (39.4 mg, 53.7 µmol) was added and the resulting mixture was heated to 45°C while a solution 
of enone 19 (514 mg, 1.34 mmol) in CH2Cl2 (2 mL) was added dropwise through the septum over the 
course of 1 h via syringe pump. After 16 h, the mixture was cooled to RT, another batch of Zhan-
catalyst 1B 32 (19.7 mg, 26.9 µmol) was added and stirring continued at 45°C. This procedure was 
repeated once again after additonal 12 h. After an overall reaction time of 48 h, the mixture was 
concentrated and the residue purified by flash chromatography (hexanes/EtOAc 14:1 to 12:1 to 9:1) to 
yield the title compound as a pale orange oil (716 mg, 79%).      
  = +41.2 (c = 0.96, CH2Cl2). 
1
H 
NMR (400 MHz, CDCl3): δ = 7.67 – 7.60 (ddd, J = 7.9, 3.8, 1.7 Hz, 4H), 7.44 – 7.34 (m, 6H), 7.34 – 
7.25 (m, 5H), 6.92 (dd, J = 16.2, 6.8 Hz, 1H), 6.06 (dd, J = 16.2, 1.5 Hz, 1H), 4.48 (d, J = 11.9 Hz, 
1H), 4.43 (d, J = 11.9 Hz, 1H), 4.25 – 4.16 (m, 1H), 3.85 (dt, J = 8.3, 4.2 Hz, 1H), 3.64 (dd, J = 5.5, 
1.5 Hz, 2H), 3.55 – 3.43 (m, 2H), 3.04 (d, J = 3.9 Hz, 1H), 2.82 – 2.66 (m, 2H), 2.53 – 2.41 (m, 1H), 
1.79 – 1.69 (m, 1H), 1.62 – 1.52 (m, 1H), 1.05 (s, 9H), 1.01 (d, J = 6.9 Hz, 3H), 0.92 (t, J = 7.9 Hz, 
9H), 0.57 (q, J = 8.0 Hz, 6H). ppm. 
13
C NMR (100 MHz, CDCl3): δ = 199.8, 150.5, 138.4, 135.5, 
135.5, 133.2, 133.2, 130.4, 129.8, 128.3, 127.7, 127.7, 127.6, 73.0, 72.4, 68.5, 67.1, 66.8, 42.6, 42.6, 
33.9, 26.9, 19.3, 14.2, 7.0, 5.1 ppm. IR (film): ṽ = 3512, 3071, 2955, 2932, 2875, 1664, 1624, 1456, 
1427, 1362, 1238, 1186, 1112, 1007, 823, 739, 701 cm
-1
. MS (ESIpos) m/z (%) = 697.5 (100 
(M+Na
+
)). HRMS (ESIpos): calcd for C40H58O5Si2Na: 697.3715; found: 697.3720. 
 
(6R,8R,11R,12R,E)-12-(2-(Benzyloxy)ethyl)-14,14-diethyl-8-hydroxy-2,2,11-trimethyl-3,3-





 (0.096 M in THF, 3.80 mL, 0.363 mmol) was slowly 
added at 50°C alongside the cold wall of the flask to a 
solution of enone 24 (700 mg, 1.04 mmol) and freshly distilled 
isobutyraldehyde (473 µL, 5.19 mmol) in degassed THF 
(9.4 mL). The mixture was stirred for 1 h at 50°C before it 
was poured into sat. aq. NaHCO3 (65 mL). The mixture was diluted with EtOAc (40 mL overall) and 
vigorously stirred until ambient temperature was reached. The phases were separated, the aqueous 
layer was extracted with EtOAc (3 x 40 mL), and the combined extracts were washed with brine 
                                                 
11
  For the preparation of SmI2, see: M. Szostak, M. Spain, D. J. Procter, Nature Protocols 2012, 7, 970-977. 
23 
(60 mL), dried over Na2SO4 and concentrated. During concentration, a small amount of SiO2 was 
added and the crude product loaded on a silica gel column, from which the title compound was eluted 
with hexanes/EtOAc (12:1 to 9:1); colorless oil (598 mg, 78%).      
  = +27.2 (c = 1.32, CH2Cl2). 
1
H 
NMR (400 MHz, CDCl3): δ = 7.67 – 7.61 (m, 4H), 7.44 – 7.27 (m, 11H), 5.69 (ddd, J = 15.8, 6.9, 
1.2 Hz, 1H), 5.43 (ddd, J = 15.6, 6.2, 1.3 Hz, 1H), 5.16 (ddt, J = 9.4, 5.5, 4.1 Hz, 1H), 4.47 (d, J = 
11.9 Hz, 1H), 4.43 (d, J = 11.9 Hz, 1H), 3.99 (ddd, J = 9.8, 6.3, 3.5 Hz, 1H), 3.71 (m, 3H), 3.50 (dd, J 
= 7.4, 5.9 Hz, 2H), 2.73 (br s, 1H), 2.56 (hep, J = 7.0 Hz, 1H), 2.33 – 2.21 (m, 1H), 1.77 – 1.53 (m, 
4H), 1.18 (d, J = 7.2 Hz, 3H), 1.16 (d, J = 7.2 Hz, 3H), 1.02 (s, 9H), 0.95 – 0.89 (m, 12H), 0.56 (q, J = 
8.1 Hz, 6H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 178.0, 138.5, 135.6, 135.5, 133.3, 133.3, 133.2, 
131.8, 129.8, 129.7, 128.3, 127.7, 127.7, 127.5, 73.2, 73.0, 71.9, 68.3, 67.2, 65.7, 42.0, 39.0, 34.2, 
33.7, 26.7, 19.2, 19.2, 19.0, 15.3, 7.0, 5.2 ppm. IR (film): ṽ = 3502, 2956, 2932, 2875, 1732, 1457, 
1428, 1388, 1362, 1239, 1196, 1160, 1111, 1007, 975, 823, 738, 701, 612 cm
-1
. MS (ESIpos) m/z (%) 
= 769.5 (100 (M+Na
+
)). HRMS (ESIpos): calcd for C44H66O6Si2Na: 769.4290; found: 769.4291. 
 
(6R,8R,11R,12R,E)-12-(2-(Benzyloxy)ethyl)-8-((tert-butyldiphenylsilyl)oxy)-14,14-diethyl-2,2,11-
trimethyl-3,3-diphenyl-4,13-dioxa-3,14-disilahexadec-9-en-6-yl isobutyrate (25a). TBDPSCl 
(284 µL, 1.09 mmol) was added at 0°C to a solution of the 
homoallylic alcohol 25 (584 mg, 0.782 mmol) and imidazole 
(90.5 mg, 1.33 mmol) in CH2Cl2 (5.2 mL). After 5 min, the 
mixture was allowed to reach ambient temperature and stirring 
was continued for 17 h before the reaction was quenched with 
sat. NH4Cl solution (25 mL) and extracted with CH2Cl2 (4 x 20 mL). The combined extracts were 
dried over Na2SO4 and concentrated, and the residue purified by flash chromatography 
(hexanes/EtOAc 39:1) to yield the title compound as a colorless syrup (671 mg, 87%).      
  = +36.7 
(c = 1.00, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 7.67 – 7.60 (m, 8H), 7.44 – 7.25 (m, 17H), 5.34 
(dd, J = 15.9, 6.8 Hz, 1H), 5.27 (dd, J = 15.8, 5.5 Hz, 1H), 5.20 – 5.10 (m, 1H), 4.51 – 4.46 (d, J = 
11.9 Hz, 1H), 4.42 (d, J = 11.9 Hz, 1H), 4.14 (td, J = 7.5, 5.3 Hz, 1H), 3.67 – 3.53 (m, 3H), 3.49 – 
3.36 (m, 2H), 2.43 (hep, J = 7.0 Hz, 1H), 2.05 – 1.96 (m, 1H), 1.89 (ddd, J = 14.0, 7.7, 4.9 Hz, 1H), 
1.77 (ddd, J = 14.1, 7.9, 5.3 Hz, 1H), 1.62 – 1.52 (m, 1H), 1.45 – 1.34 (m, 1H), 1.10 (d, J = 6.9 Hz, 
6H), 1.02 (s, 18H), 0.89 (t, J = 7.9 Hz, 9H), 0.73 (d, J = 6.9 Hz, 3H), 0.52 (q, J = 7.9 Hz, 6H) ppm. 
13
C 
NMR (100 MHz, CDCl3): δ = 176.1, 138.7, 136.0, 135.9, 135.6, 135.5, 134.7, 134.0, 133.5, 133.5, 
133.3, 129.6, 129.6, 129.4, 129.2, 128.3, 127.6, 127.6, 127.4, 127.2, 73.0, 72.9, 72.0, 71.4, 67.2, 65.2, 
41.7, 39.8, 34.1, 33.5, 27.0, 26.8, 19.2, 19.0, 18.9, 15.0, 7.0, 5.1 ppm. IR (film): ṽ = 2956, 2932, 2875, 
2858, 1734, 1471, 1427, 1387, 1361, 1259, 1191, 1157, 1105, 1007, 977, 822, 736, 698 cm
-1
. MS (EI) 
m/z (%) = 927 (2), 820 (2), 561 (2), 509 (6), 493 (7), 469 (4), 467 (4), 377 (5), 322 (3), 319 (3), 280 
(22), 279 (97), 269 (26), 199 (16), 174 (15), 173 (100), 171 (14), 135 (22), 131 (44), 91 (57), 73 (16). 
HRMS (ESIpos): calcdfor C60H84O6Si3Na: 1007.5468; found: 1007.5473. 
24 
(6R,8R)-8-((3R,4R,E)-6-(Benzyloxy)-4-hydroxy-3-methylhex-1-en-1-yl)-2,2,11,11-tetramethyl-
3,3,10,10-tetraphenyl-4,9-dioxa-3,10-disiladodecan-6-yl isobutyrate (26). Camphorsulfonic acid 
(47.7 mg, 0.205 mmol) was added at 0°C to a solution of 
compound 25a (675 mg, 0.685 mmol) in CH2Cl2/MeOH (2:1, 
12.6 mL). The resulting mixture was stirred for 90 min before 
the reaction was carefully quenched with sat. NaHCO3 (40 mL) 
solution. After extraction with CH2Cl2 (3 x 40 mL), the 
combined organic phases were washed with brine, dried over Na2SO4 and concentrated to give a 
colorless oil, which was purified by flash chromatography (hexanes/EtOAc 8:1) to give the title 
compound as a colorless oil (576 mg, 97%).      
  = +22.9 (c = 1.32, CH2Cl2). 
1
H NMR (400 MHz, 
CDCl3): δ = 7.64 – 7.57 (m, 8H), 7.43 – 7.25 (m, 18H), 5.35 (dd, J = 15.5, 7.9 Hz, 1H), 5.14 – 5.06 
(m, 1H), 4.98 (dd, J = 15.5, 7.9 Hz, 1H), 4.45 (s, 2H), 4.08 (q, J = 7.0 Hz, 1H), 3.57 (d, J = 4.8 Hz, 
2H), 3.51 – 3.37 (m, 2H), 3.30 (br t, 1H), 2.51 – 2.37 (m, 2H), 1.91 (ddd, J = 11.5, 7.4, 4.6 Hz, 2H), 
1.73 (dt, J = 13.6, 6.5 Hz, 1H), 1.44 – 1.29 (m, 3H), 1.09 (d, J = 6.9 Hz, 6H), 0.99 (d, J = 7.7 Hz, 
18H), 0.79 (d, J = 6.8 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): 176.2, 138.0, 135.9, 135.9, 135.6, 
135.5, 134.6, 134.2, 133.6, 133.4, 133.4, 132.8, 129.6, 129.6, 129.6, 129.3, 128.4, 127.7, 127.6, 127.5, 
127.3, 74.0, 73.3, 72.0, 69.3, 65.2, 42.3, 39.7, 34.1, 33.5, 26.9, 26.7, 19.2, 19.0, 19.0, 15.0 ppm. IR 
(film): ṽ = 3511, 2960, 2931, 2858, 1734, 1472, 1427, 1389, 1361, 1260, 1193, 1158, 1111, 1082, 976, 
822, 739, 701 cm
-1
. MS (EI) m/z (%) = 527 (5), 467 (8), 393 (28), 363 (27), 319 (11), 271 (12), 270 
(18), 269 (81), 209 (11), 200 (13), 199 (71), 197 (19), 135 (48), 108 (21), 91 (100), 81 (11), 43 (15). 




(27). According to a modified protocol from Denmark et. al.,
12
 a 
solution of alcohol 26 (574 mg, 0.659 mmol) in CH2Cl2 (10 mL) 
was prepared and cooled to 40°C. N-(Phenylseleno)phthalimide 
(239 mg, 0.791 mmol) followed by a solution of 
triphenylphosphine sulfide (23.3 mg, 79.1 µmol) and trifluoroacetic acid (56.7 µL, 0.791 mmol) in 
CH2Cl2 (1 mL) were added via syringe over 5 min. After complete addition, the mixture was allowed 
to warm to 20°C and stirring was continued for 3 h before the mixture was poured into a stirred 
emulsion of sat. aq. NaHCO3 and CH2Cl2 (1:1, 40 mL). The aqueous phase was extracted with CH2Cl2 
(3 x 15 mL), the combined organic extracts were dried over Na2SO4 and concentrated. 
1
H NMR and 
HPLC analysis of the crude mixture revealed a d.r. of 14:1. The residue was purified by flash 
chromatography (hexanes/EtOAc 100:0 to 49:1 to 29:1 to 24:1) to give the cyclized product as a 
colorless oil (560 mg, 83% yield, 14:1 d.r.). An analytically pure sample was obtained by preparative 
                                                 
12
  S. E. Denmark, D. Kalyani, W. R. Collins, J. Am. Chem. Soc. 2010, 132, 15752. 
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HPLC (Triart C18 5 µm, 12 nm, 150x30 mm, 100% MeCN, 35°C, 35bar, 35mL/min).      
  = +1.1 (c 
= 0.93, CH2Cl2). 
1
H NMR (600 MHz, CDCl3): see Table 1. 
13
C NMR (150 MHz, CDCl3): δ = 176.0, 
138.7, 136.1, 135.8, 135.6, 135.6, 134.4, 134.4, 133.6, 133.4, 133.3, 129.6, 129.6, 129.3, 129.2, 129.1, 
128.3, 127.7, 127.7, 127.6, 127.4, 127.3, 127.1, 85.8, 72.9, 72.7, 71.6, 67.9, 65.3, 49.6, 44.6, 36.1, 
34.1, 30.6, 29.7, 27.1, 26.7, 19.7, 19.2, 19.0, 18.8, 14.9 ppm. IR (film): ṽ = 2961, 2929, 2855, 1733, 
1472, 1427, 1361, 1260, 1192, 1111, 1021, 821, 802, 738, 701 cm
-1
. MS (EI) m/z (%) = 970 (6), 969 
(9), 883 (9), 882 (13), 881 (22), 880 (8), 879 (11), 805 (11), 724 (11), 723 (11), 563 (11), 467 (10), 
361 (25), 349 (11), 319 (13), 296 (11), 295 (45), 270 (23), 269 (100), 241 (14), 239 (34), 200 (13), 199 
(73), 197 (30), 136 (12), 135 (93), 91 (84), 43 (13). HRMS (ESIpos): calcd for C60H74O6Si2SeNa: 




Table 1: Assignment & NOESY relations for the aliphatic 
signals of major cyclization isomer 27;
13
 numbering scheme 





H /ppm multiplet J / Hz 
13
C /ppm COSY NOESY 
1 3.52 dd 10.9, 4.1 65.3 1a, 2 1a,2,(3a) 
1a 3.45 dd 10.9, 5.4 - 1, 2 1,2,(3a) 
2 5.12 m - 71.6 1, 1a, 3, (3a) 1, 1a(3),3a,(4) 
3 2.16 ddd 14.6, 9.8, 3.9 36.1 2, 3a, 4 3a, (4),(5),6 
3a 1.73 ddd 14.7, 7.1, 2.8 - 2, 3, 4 3, (4), (5) 
4 3.68 ddd 6.9, 6.9, 3.8 72.7 3, 3a, 5 2,3a,6 
5 3.63 dd 6.5, 6.5 85.8 4, 6 (6),7,8,(3a) 
6 2.93 dd 6.3, 3.5 49.6 5, 7 4,(8),12 
7 2.07 ddq 12.4, 7.1, 3.6 44.6 6, 8, 12  (5),6,8,12 
8 3.85 ddd 8.2, 5.5, 5.0 77.1 7, 9 5,7,9,9a,10,10a 
9 1.46 m - 30.6 8, 10, 10a 8,10,10a,12 
9a 1.46 m - - 8, 10, 10a 8,10,10a,12 
10 3.11 m - 67.9 9, 9a 8,9,9a,11,11a 
10a 3.11 m - - 9, 9a 8,9,9a,11,11a 
11 4.32 s - 72.9 - 10,10a 
11a 4.32 s - - - 10,10a 
12 0.49 d 7.14 14.9 7 (4),6,7,9,9a 
13 - - - 176.0 - - 
14 2.40 hept 7.0 30.6 15, 15a 15,15a 
15 1.07 d 7.0 18.8 14 14, 15a 
15a 1.05 d 7.0 19.0 14 14, 15 
16 - - - 19.7 - 1, 1, 17 
16a - - - 19.2 - 4, 17a 
17 0.98 s - 27.1 - 1, 1a, 16 
17a 1.01 s - 26.7 - 4, 16a 
 
                                                 
13
  The aromatic signals were not assigned, they were found at: δ = 7.69 – 7.66 (m, 2H), 7.64 – 7.60 (m, 6H), 






Obtained as the minor isomer by preparative HPLC (conditions 
see above) as a colorless oil. 
1
H NMR (600 MHz, CDCl3): see 
Table 2. 
13
C NMR (150 MHz, CDCl3): δ = 176.1, 138.5, 136.1, 
136.0, 135.6, 135.5, 134.2, 133.5, 133.4, 133.4, 133.1, 132.5, 
130.9, 130.6, 129.6, 129.6, 129.4, 129.0, 128.8, 128.4, 127.7, 127.6, 127.6, 127.5, 127.3, 127.0, 83.3, 
78.7, 73.0, 71.9, 71.6, 68.0, 65.3, 48.1, 40.2, 34.0, 33.6, 31.9, 27.1, 26.7, 19.4, 19.2, 19.0, 18.9, 11.6 
ppm. IR (film): ṽ = 2962, 2930, 2854, 1732, 1472, 1427, 1360, 1260, 1192, 1110, 1021, 823, 799, 738, 
701 cm
-1
. MS (EI) m/z (%) = 970 (6), 969 (9), 883 (10), 882 (14), 881 (22), 880 (8), 879 (11), 805 
(11), 724 (11), 723 (11), 563 (11), 467 (11), 361 (25), 349 (11), 319 (13), 296 (12), 295 (47), 270 (23), 
269 (100), 241 (14), 239 (34), 200 (13), 199 (73), 197 (30), 135 (93), 91 (84). HRMS (ESIpos): calcd 
for C60H74O6Si2SeNa: 1049.4081; found: 1049.4075. 
 
Table 2: Assignment & NOESY relations for the aliphatic 
signals of minor cyclization isomer;
15
 numbering scheme as 




H /ppm multiplet J /Hz 
13
C /ppm COSY NOESY 
1 3.53 dd 11.0, 3.9 - 2, 1 1a, 2 (15) 
1a 3.41 dd 10.9, 5.2 65.3 2, 1a 1, 2, (15) 
2 5.02 m - 71.6 1, 3, 3a 1, 1a, 3a, 4 
3 1.99 ddd 14.5, 9.9, 4.3 33.6 2, 3a, 4 3a, 4, 6 
3a 1.80 m - - 2, 3, 4 2, 3, 4 
4 4.04 ddd 7.9, 4.1, 1.4 71.9 3, 3a, (5) 2, 3, 5, 6 
5 3.92 dd 9.9, 1.3 83.3 (4), 6 4, 6, 12 
6 3.67 dd 9.9, 6.2 48.1 5, 7 4, 5, 8, 3, 7 
7 2.20 m - 40.2 6, (8), 12 6, 8 
8 3.98 ddd 8.8, 4.5, 4.5 78.7 (7), 9, (9a) 6, 7, 9, 9a, 10 
9 1.82 m - 31.9 8, 10, 10a (8), 9a, (10a), 10, 12 
9a 1.73 ddd 13.7, 7.3, 5.0 - (8), 10, 10a (8), 9, 10, 10a, 12 
10 3.59 ddd 9.1, 7.7, 5.4 68.0 9, 9a, 10a 9, (9a), 10a, 11, 11a 
10a 3.50 dd 9.2, 7.2 - 9, 9a, 10 9, (9a), 10, 11, 11a 
11 4.48 d 13.8 73.0 - 10, 10a, 11a 
11a 4.48 d 13.8 - - 10, 10a, 11a 
12 0.86 d 7.1 11.6 7 5, 7, 9 
13 - - - 176.1 - - 
14 2.27 hept - 34.0 15, 15a 15, 15a 
15 1.00 d 7.0 19.0 14, 15a 14, 15a 
15a 0.99 d 7.0 18.9 14, 15 14, 15 
16 - - - 19.2 - - 
16a - - - 19.4 - - 
17 0.97 s - 26.7 - 1, (1a) 
17a 1.01 s - 27.1 - 4 
                                                 
14
  This compound was isolated after the reaction of alcohol 26 with PhSeBr in MeCN, which gave a 2.6:1 ratio 
of 27:undesired isomer. 
15
  The aromatic signals were not assigned, they were found at: δ = 7.70 – 7.67 (m, 3H), 7.63 – 7.60 (m, 2H), 
7.60 – 7.56 (m, 4H), 7.53 – 7.49 (m, 1H), 7.40 – 7.24 (m, 17H), 7.23 – 7.14 (m, 3H) ppm. 
27 
 





Additional support for this assignment was obtained by comparison of the chemical shift of H6 of the 
two isomers. As reported in the literature,
12,13
 the chemical shift is strongly dependent on the number 
of syn-alkyl groups, which cause an up-field shift. 
 
Compound # of syn-alkyl groups  (H6) /ppm  (Lit.)16,17 /ppm 
27 (major isomer) 2 2.93 2.80 
minor isomer 1 3.67 3.50 




methyl-3,3,10,10-tetraphenyl-4,9-dioxa-3,10-disiladodecan-6-yl isobutyrate (27a). A flame-dried 
two-necked round-bottom flask equipped with a reflux condenser 
was charged with a solution of selenoether 27 (560 mg, 
0.546 mmol) in degassed toluene (22 mL). (nBu)3SnH (177 µL, 
0.655 mmol) was added via syringe, followed by solid AIBN 
(0.9 mg, 5.5 µmol). The resulting mixture was stirred at 80°C for 90 min under Argon, allowing the 
generated N2 to evaporate. After cooling to room-temperature, the mixture was concentrated and the 
residue purified by flash chromatography (hexanes/EtOAc 100:0 to 49:1 to 39:1 to 29:1) to yield the 
title compound as a sticky colorless syrup (440 mg, 93% yield, single d.r.).      
  = +34.1 (c = 0.95, 
CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 7.71 – 7.61 (m, 8H), 7.42 – 7.25 (m, 17H), 5.24 – 5.17 (m, 
1H), 4.30 (s, 2H), 3.72 – 3.63 (m, 2H), 3.61 – 3.54 (m, 3H), 3.15 – 3.03 (m, 2H), 2.36 (hep, J = 
                                                 
16
  E. D. Mihelich, G. A. Hite, J. Am. Chem. Soc. 1992, 114, 7318.  
17
  D. R. Williams, Y. Harigaya, J. L. Moore, A. D’sa, J. Am. Chem. Soc. 1984, 106, 2641. 
28 
7.0 Hz, 1H), 2.05 (dddd, J = 13.3, 11.7, 6.7, 5.4 Hz, 1H), 1.94 (ddd, J = 12.3, 7.3, 7.2 Hz, 1H), 1.83 
(ddd, J = 14.1, 9.1, 0.2 Hz, 1H), 1.72 (ddd, J = 14.4, 7.6, 2.9 Hz, 1H), 1.51 – 1.37 (m, 2H), 1.06 – 0.99 
(m, 25H), 0.61 (d, J = 6.9 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 176.1, 138.8, 136.2, 135.9, 
135.6, 135.5, 135.0, 133.8, 133.5, 133.4, 129.6, 129.3, 129.0, 128.3, 127.7, 127.6, 127.6, 127.6, 127.4, 
127.3, 127.0, 80.8, 78.3, 73.2, 72.8, 71.3, 68.2, 63.4, 36.1, 35.6, 35.2, 34.0, 31.0, 27.2, 26.7, 19.6, 
19.3, 19.0, 18.8, 15.6 ppm. IR (film): ṽ = 2959, 2930, 2856, 1734, 1471, 1427, 1388, 1361, 1258, 
1192, 1157, 1110, 998, 937, 822, 738, 700 cm
-1
. MS (EI) m/z (%) = 814 (16), 813 (25), 726 (18), 725 
(29), 563 (14), 558 (17), 557 (37), 469 (12), 319 (12), 301 (13), 296 (13), 295 (47), 271 (11), 270 (23), 
269 (100), 241 (24), 239 (29), 200 (14), 199 (77), 197 (25), 163 (13), 136 (10), 135 (80), 91 (96). 
HRMS (ESIpos): calcd for C54H70O6Si2Na: 893.4603; found: 893.4594. 
 
(6R,8R)-8-((2R,4R,5R)-5-(2-Hydroxyethyl)-4-methyltetrahydrofuran-2-yl)-2,2,11,11-tetramethyl-
3,3,10,10-tetraphenyl-4,9-dioxa-3,10-disiladodecan-6-yl isobutyrate (27b). A flame-dried Schlenk 
tube was charged with Pd(OH)2/C (20 wt. %, 35.5 mg, 
50.5 µmol). The flask was evacuated (5 x 10
-1
 mbar) and 
backfilled with H2 from a balloon (two cycles). EtOH (27 mL) 
was added and the suspension vigorously stirred for 10 min 
before a solution of benzyl ether 27a (440 mg, 0.505 mmol) in EtOAc (3 mL) was introduced. After 
stirring for 7.5 h under a H2 atmosphere (balloon), the mixture was filtered through a short pad of 
Celite that was carefully rinsed with EtOAc (3 x 20 mL). The combined filtrates were concentrated 
and the residue was purified by flash chromatography (hexanes/EtOAc 4:1) to yield the desired 
product as a white foam (345 mg, 88%).      
  = +24.2 (c = 0.88, CH2Cl2). 
1
H NMR (400 MHz, 
CDCl3): δ = 7.71 – 7.60 (m, 8H), 7.44 – 7.28 (m, 12H), 5.12 (ddd, J = 9.6, 4.8, 4.9, 3.1 Hz, 1H), 3.75 – 
3.66 (m, 3H), 3.58 – 3.51 (m, 2H), 3.49 – 3.35 (m, 2H), 2.36 (hep, J = 7.0 Hz, 1H), 2.14 (dddd, J = 
14.1, 14.1, 7.1, 6.9 Hz, 1H), 2.00 – 1.89 (m, 3H), 1.88 (dd, J = 9.6, 3.0 Hz, 1H), 1.73 (ddd, J = 14.3, 
7.4, 3.1 Hz, 1H), 1.50 – 1.37 (m, 1H), 1.24 – 1.16 (m, 1H), 1.06 – 1.00 (m, 24H), 0.74 (d, J = 7.0 Hz, 
3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 176.1, 136.1, 135.8, 135.6, 135.5, 134.7, 133.5, 133.4, 
133.3, 129.6, 129.6, 129.5, 129.2, 127.6, 127.6, 127.4, 127.2, 80.9, 80.3, 72.2, 71.2, 65.3, 61.4, 35.5, 
35.3, 35.2, 34.0, 32.9, 27.1, 26.7, 19.5, 19.2, 19.0, 18.8, 15.5 ppm. IR (film): ṽ = 3487, 2960, 2930, 
2857, 1735, 1472, 1428, 1388, 1259, 1193, 1158, 1112, 998, 823, 740, 702, 610 cm
-1
. MS (EI) m/z 
(%) = 723 (12), 646 (10), 645 (18), 636 (13), 635 (23), 563 (12), 558 (20), 557 (41), 437 (16), 379 
(31), 319 (13), 301 (18), 295 (34), 270 (18), 269 (82), 241 (32), 239 (32), 200 (18), 199 (97), 197 (38), 
183 (12), 181 (14), 163 (14), 145 (11), 139 (12), 137 (12), 136 (14), 135 (100), 85 (29), 71 (14), 43 





3,3,10,10-tetraphenyl-4,9-dioxa-3,10-disiladodecan-6-yl isobutyrate (28). A solution of the primary 
alcohol 27b (341 mg, 0.437 mmol) in CH2Cl2 (1 mL + 2 x 0.5 mL 
rinse) was added dropwise at 0°C to a solution of Dess-Martin 
periodinane (463 mg, 1.09 mmol) in CH2Cl2 (2.6 mL). After 
complete addition, the ice bath was removed and stirring continued 
at RT for 4.5 h before the reaction was quenched with sat. Na2S2O3 and sat. NaHCO3 solution (1:1, 
20 mL). The aqueous phase was extracted with CH2Cl2 (3 x 15 mL), and the combined extracts were 
dried over Na2SO4 and concentrated. The residue was purified flash chromatography (short column, 
hexanes/EtOAc 19:1) to give the desired aldehyde as a colorless sticky syrup (310 mg, 91%).      
  = 
+35.2 (c = 0.57, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 9.13 (t, J = 2.2 Hz, 1H), 7.70 – 7.59 (m, 
8H), 7.46 – 7.25 (m, 12H), 5.18 (dddd, J = 9.5, 4.8, 4.7, 3.0 Hz, 1H), 3.93 (ddd, J = 8.8, 6.5, 4.7 Hz, 
1H), 3.75 – 3.63 (m, 2H), 3.58 (d, J = 4.7 Hz, 2H), 2.37 (hep, J = 7.0 Hz, 1H), 2.25 – 2.19 (m, 1H), 
2.16 (dd, J = 8.6, 1.8 Hz, 1H), 2.10 (ddd, J = 16.2, 4.9, 2.5 Hz, 1H), 2.02 – 1.92 (m, 1H), 1.83 (ddd, J 
= 14.2, 9.5, 2.5 Hz, 1H), 1.73 (ddd, J = 14.4, 7.6, 3.1 Hz, 1H), 1.14 – 1.09 (m, 1H), 1.05 (d, J = 7.0 
Hz, 3H), 1.04 (d, J = 7.1 Hz, 3H), 1.02 (s, 9H), 0.99 (s, 9H), 0.63 (d, J = 7.0 Hz, 3H) ppm. 
13
C NMR 
(100 MHz, CDCl3): δ = 202.1, 176.1, 136.1, 135.7, 135.6, 135.5, 134.8, 133.7, 133.4, 133.4, 129.7, 
129.4, 129.1, 127.7, 127.7, 127.3, 127.0, 81.3, 76.3, 72.9, 71.2, 65.3, 44.8, 35.8, 35.5, 35.2, 34.0, 27.1, 
26.7, 19.6, 19.3, 19.0, 18.8, 15.6 ppm. IR (film): ṽ = 2959, 2929, 2856, 1729, 1472, 1427, 1388, 1240, 
1192, 1158, 1111, 998, 822, 740, 701 cm
-1
. MS (EI) m/z (%) = 721 (7), 635 (16), 634 (42), 633 (80), 
563 (7), 377 (15), 319 (11), 295 (31), 270 (22), 269 (100), 241 (14), 239 (21), 225 (10), 200 (12), 199 
(66), 197 (29), 183 (13), 179 (15), 163 (12), 136 (10), 136 (78), 43 (19). HRMS (ESIpos): calcd for 
C47H62O6Si2Na: 801.3977; found: 801.3977. 
 
(6R,8R)-2,2,11,11-Tetramethyl-8-((2R,4R,5R)-4-methyl-5-(prop-2-yn-1-yl)tetrahydrofuran-2-yl)-
3,3,10,10-tetraphenyl-4,9-dioxa-3,10-disiladodecan-6-yl isobutyrate (29). A flame-dried Schlenk 
tube was charged with dimethyl-1-diazo-2-oxopropylphosphonate 
(33) (306 mg, 1.592 mmol) and THF (8 mL). The resulting solution 
was cooled to 78°C before a freshly prepared solution of NaOMe 
(0.5 M, 3.18 mL, 1.592 mmol)
18
was added over the course of 10 min 
via syringe, causing the mixture to turn intensively yellow. After stirring for 15 min at 78°C, a 
precooled (78°C) solution of aldehyde 28 (310 mg, 0.398 mmol) in THF (5 mL + 2 x 1 mL rinse) 
was added slowly via canula. The reaction flask was then equipped with an Argon bubbler to allow the 
generated N2 to evaporate. The mixture was slowly warmed to 50°C, causing a heavy gas evolution. 
After stirring for 90 min at 50°C, the reaction was quenched by addition of sat. NH4Cl solution 
                                                 
18
  A solution of NaOMe was prepared by adding an equimolar amount of MeOH to a suspension of NaH in 
THF at 0°C, which was allowed to stir at room-temperature until gas evolution had ceased (~1 h). 
30 
(20 mL) and H2O (4 mL) and the aqueous layer was extracted with EtOAc (4 x 30 mL). The combined 
extracts were washed with brine (35 mL), dried over Na2SO4 and concentrated. The orange residue 
was purified by flash chromatography (hexanes/EtOAc 39:1) to yield the desired alkyne as a white 
foam that collapsed upon storage (287 mg, 93%).      
  = +19.4 (c = 1.10, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ = 7.72 – 7.57 (m, 8H), 7.48 – 7.25 (m, 12H), 5.13 (dddd, J = 9.5, 4.7, 4.6, 
2.9 Hz, 1H), 3.78 – 3.64 (m, 3H), 3.57 (d, J = 4.7 Hz, 2H), 2.35 (hep, J = 7.0 Hz, 1H), 2.24 (ddd, J = 
14.0, 7.0, 7.0 Hz, 1H), 2.05 – 2.00 (m, 2H), 1.97 – 1.84 (m, 2H), 1.83 (t, J = 2.7 Hz, 1H), 1.71 (ddd, J 
= 14.5, 7.8, 3.0 Hz, 1H), 1.27 – 1.15 (m, 1H), 1.06 – 0.98 (m, 24H), 0.81 (d, J = 7.0 Hz, 3H) ppm. 13C 
NMR (100 MHz, CDCl3): δ = 176.1, 136.1, 135.9, 135.6, 135.5, 134.7, 134.0, 133.5, 133.4, 129.6, 
129.6, 129.3, 129.1, 127.7, 127.6, 127.3, 127.0, 81.6, 81.0, 79.3, 72.7, 71.2, 69.1, 65.3, 35.2, 35.1, 
34.0, 27.2, 26.7, 20.6, 19.6, 19.2, 19.0, 18.8, 14.8 ppm. IR (film): ṽ = 2960, 2930, 2857, 1735, 1472, 
1428, 1388, 1260, 1192, 1158, 1112, 1006, 822, 740, 702 cm
-1
. MS (ESIpos) m/z (%) = 797.5 (100 
(M+Na
+
)). HRMS (ESIpos): calcd for C48H62O5Si2Na: 797.4028; found: 797.4028. 
 
(6R,8R)-2,2,11,11-Tetramethyl-8-((2R,4R,5R)-4-methyl-5-(prop-2-yn-1-yl)tetrahydrofuran-2-yl)-
3,3,10,10-tetraphenyl-4,9-dioxa-3,10-disiladodecan-6-ol (30). A solution of DIBAL-H in toluene 
(1.0 M, 1.10 mL, 1.10 mmol) was added dropwise at 78°C to a 
solution of ester 29 (285 mg, 0.368 mmol) in toluene (24 mL) and the 
resulting mixture was stirred for 30 min at this temperature. The 
mixture was then poured via canula into a stirred sat. solution of 
Rochelle salt (150 mL), the flask was rinsed with EtOAc (2 x 20 mL) and the emulsion was vigorously 
stirred at ambient temperature for 4 h. The layers were separated, the aqueous phase was extracted 
with EtOAc (3 x 40 mL), and the combined organic extracts were dried over Na2SO4 and concentrated. 
The crude residue was purified by flash chromatography (hexanes/EtOAc 24:1 to 19:1) to give the title 
compound as a sticky colorless syrup (252 mg, 97%).      
  = +18.2 (c = 1.07, CHCl3). 
1
H NMR 
(400 MHz, CDCl3): δ = 7.75 – 7.68 (m, 4H), 7.64 – 7.59 (m, 4H), 7.45 – 7.28 (m, 12H), 4.06 (ddd, J = 
6.7, 6.6, 4.1 Hz, 1H), 3.90 – 3.74 (m, 3H), 3.43 (d, J = 5.6 Hz, 2H), 2.60 (d, J = 3.4 Hz, 1H), 2.30 
(hep, J = 7.1 Hz, 1H), 2.13 (ddd, J = 16.7, 6.0, 2.5 Hz, 1H), 2.07 (ddd, J = 16.6, 7.6, 2.6 Hz, 1H), 1.95 
(ddd, J = 12.5, 7.8, 6.9 Hz, 1H), 1.86 (t, J = 2.7 Hz, 1H), 1.62 (ddd, J = 14.3, 9.3, 4.2 Hz, 1H), 1.56 
(ddd, J = 14.4, 6.9, 3.1 Hz, 1H), 1.30 (ddd, J =12.5, 9.0, 7.4 Hz, 1H), 1.06 (s, 9H), 1.03 (s, 9H), 0.87 
(d, J = 7.0 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 136.1, 136.0, 135.5, 135.5, 134.2, 134.1, 
133.4, 133.4, 129.7, 129.4, 129.4, 127.7, 127.4, 127.2, 81.6, 81.0, 79.5, 73.2, 69.3, 68.8, 68.3, 36.6, 
35.2, 35.1, 27.1, 26.8, 20.8, 19.6, 19.2, 14.8 ppm. IR (film): ṽ = 3311, 2957, 2928, 2856, 1472, 1469, 
1427, 1390, 1362, 1269, 1189, 1111, 999, 822, 739, 701 cm
-1
. MS (EI) m/z (%) = 570 (22), 569 (48), 
491 (8), 417 (7), 319 (18), 299 (10), 259 (12), 257 (14), 241 (35), 239 (19), 223 (11), 221 (35), 200 
(19), 199 (100), 197 (40), 183 (17), 181 (14), 175 (16), 163 (22), 149 (34), 139 (13), 136 (12), 135 
31 
(88), 117 (17), 93 (12), 91 (22), 79 (12). HRMS (ESIpos): calcd for C44H56O4Si2Na: 727.3609; found: 
727.3610. 
Allyl α-L-rhamnopyranoside (35). L-Rhamnose (34) (4.0 g, 22 mmol) was dissolved in allyl alcohol 
(30 mL) and conc. H2SO4 (0.4 mL) was added. The mixture was stirred at 
100°C for 1 h while its color changed to brown. After cooling to ambient 
temperature, solid K2CO3 (60 mg) was added and excess allyl alcohol was 
removed under reduced pressure. The residue was purified by flash 
chromatography (EtOAc) to yield the targeted compound as highly viscous colorless oil (3.5 g, 78%). 
     
  = 83.0 (c = 1.29, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 5.85 (dddd, J = 17.2, 10.3, 6.1, 5.2 
Hz, 1H), 5.25 (dq, J = 17.3, 1.6 Hz, 1H), 5.16 (dq, J = 10.4, 1.3 Hz, 1H), 4.77 (d, J = 1.5 Hz, 1H), 4.74 
– 4.56 (s, 1H), 4.39 – 4.23 (br s, 1H), 4.30 – 4.17 –(br s, 1H), 4.12 (ddt, J = 13.0, 5.3, 1.5 Hz, 1H), 
4.03 – 3.86 (m, 2H), 3.75 (dd, J = 9.5, 3.3 Hz, 1H), 3.61 (dq, J = 9.4, 6.2 Hz, 1H), 3.44 (t, J = 9.5 Hz, 
1H), 1.27 (d, J = 6.2 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 133.7, 117.5, 98.9, 72.8, 71.7, 
710, 68.2, 68.0, 17.5 ppm. IR (film): ṽ = 3371, 2977, 2915, 1450, 1422, 1383, 1265, 1128, 1046, 980, 
880, 835, 808, 734, 685 cm
-1
. MS (EI) m/z (%) = 131 (5), 100 (46), 87 (21), 85 (11), 83 (5), 74 (7), 73 
(18), 72 (5), 71 (63), 61 (13), 60 (96), 59 (11), 58 (46), 57 (26), 56 (6), 55 (10), 45 (18), 43 (41), 42 
(15), 41 (100), 39 (21), 31 (18), 29 (25), 27 (11). HRMS (ESIpos): calcd for C9H16O5Na: 227.0889; 
found: 227.0891. 
 
Compound 36. Trimethylorthoacetate (44.8 mL 350 mmol) and 2,3-butadione (7.7 mL, 88 mmol) 
were dissolved in MeOH (200 mL) and treated with p-TsOH·H2O (1.25 g, 
6.57 mmol) before the mixture was stirred at 75°C for 24 h. After cooling to 
ambient temperature, a solution of rhamnoside 35 (3.02 g, 14.8 mmol) in 
MeOH (7 mL+7 mL rinse) was added and the mixture stirred at 75°C 
overnight. After cooling to ambient temperature, NEt3 (1.2 mL) was added to neutralize the medium 
prior to evaporation of the solvents under reduced pressure. The residue was purified by flash 
chromatography (hexanes/EtOAc 4:1) to give the desired bis-acetal as a highly viscous colorless syrup 
(3.21 g, 72%).      
  = 182.6 (c = 0.99, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 5.86 (dddd, J = 
16.8, 10.3, 6.3, 5.2 Hz, 1H), 5.24 (dq, J = 17.2, 1.7 Hz, 1H), 5.15 (dq, J = 10.4, 1.4 Hz, 1H), 4.79 (d, J 
= 1.5 Hz, 1H), 4.13 (ddt, J = 12.9, 5.2, 1.5 Hz, 1H), 4.00 – 3.87 (m, 3H), 3.78 (dq, J = 9.7, 6.0 Hz, 
1H), 3.68 (t, J = 9.9 Hz, 1H), 3.22 (s, 3H), 3.19 (s, 3H), 2.46 (d, J = 2.3 Hz, 1H), 1.27 (s, 3H), 1.24 (s, 
3H), 1.22 (d, J = 6.1 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 133.8, 117.4, 100.2, 99.8, 98.9, 
69.9, 68.4, 68.2, 67.9, 66.5, 48.0, 47.6, 17.8, 17.6, 16.5 ppm. IR (film): ṽ = 3464, 2932, 2834, 1454, 
1376, 1138, 1111, 1076, 1034, 984, 929, 915, 882, 848, 734, 701, 672 cm
-1
. MS (EI) m/z (%) = 116 
(7), 113 (7), 101 (33), 85 (7), 84 (100), 83 (23), 75 (16), 73 (11), 57 (5), 55 (11), 43 (34), 41 (21), 29 
(7). HRMS (ESIpos): calcd for C15H27O7Na: 341.1571; found: 341.1571. 
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Compound 37. A solution of bisacetal 36 (3.17 g, 10.4 mmol) in DMF (10 mL) was slowly added at 
0°C to a suspension of NaH (748 mg, 31.2 mmol) in DMF (60 mL). The 
resulting mixture was stirred for about 30 min at 0°C until gas evolution had 
ceased. MeI (1.95 mL, 31.2 mmol) was then added dropwise, causing a color 
change to yellow. The mixture was warmed to room temperature overnight 
before the reaction was quenched with aq. sat. NH4Cl (300 mL). The aqueous phase was extracted 
with EtOAc (3 x 150 mL), the combined organic extracts were washed with brine (200 mL), dried 
over Na2SO4 and concentrated. The residue was purified by flash chromatography (hexanes/EtOAc 
3:2) to give the methylated product as pale yellow oil (2.21 g, 64%).      
  = 214.0 (c = 0.88, 
CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 5.91 (m, 1H), 5.24 (dd, J = 17.3, 1.3 Hz, 1H), 5.15 (dd, J = 
10.4, 1.3 Hz, 1H), 4.82 (d, 1H, J = 1.5 Hz), 4.13 (m, 1H), 3.99 (dd, J = 9.9, 3.0 Hz, 1H), 3.93 (m, 1H), 
3.75 (dq, J = 9.8, 6.0 Hz, 1H), 3.68 (dd, J = 9.9, 9.8 Hz, 1H), 3.44 (dd, J = 3.0, 1.5 Hz, 1H), 3.47 (s, 
3H), 3.24 (s, 3H), 3.22 (s, 3H), 1.29 (s, 3H), 1.26 (s, 3H), 1.23 (d, J = 6.0 Hz, 3H) ppm. 
13
C NMR 
(100 MHz, CDCl3): δ = 133.9, 117.3, 99.8, 99.5, 97.1, 78.8, 68.7, 68.4, 67.9, 66.9, 59.2, 47.9, 47.6, 
17.8, 17.8, 16.6 ppm. IR (film): ṽ = 2932, 2832, 1453, 1375, 1197, 1138, 1114, 1083, 1037, 994, 932, 
882, 848, 815 cm
-1
. MS (EI) m/z (%) = 116 (9), 115 (11), 101 (25), 99 (11), 98 (100), 97 (17), 83 (16), 
75 (5), 73 (16), 71 (5), 67 (9), 55 (7), 45 (10), 43 (30), 41 (29), 39 (6), 29 (7). HRMS (ESIpos): calcd 
for C16H28O7Na: 355.1727; found: 355.1725. 
 
Allyl 2-O-methyl-α-L-rhamnopyranoside 37a. Trifluoroacetic acid (19 mL) was added to an 
emulsion of compound 37 (2.05 g, 6.17 mmol) in H2O (1 mL) at 0°C. The 
mixture turned slightly yellow and was allowed to stir for 7 min at this 
temperature. The mixture was diluted with CH2Cl2 (300 mL), the organic phase 
was dried over Na2SO4 and concentrated to give the diol as a pale orange oil that was used in the next 
step without further purification (1.32 g, 98%, 95% purity). An analytically pure sample was obtained 
by flash chromatography (Hex/EtOAc = 1:1 to 1:2).      
  = 46.3 (c = 1.00, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ = 5.84 (dddd, J = 17.2, 10.4, 6.1, 5.0 Hz, 1H), 5.23 (dq, J = 17.2, 1.7 Hz, 1H), 
5.14 (dq, J = 10.4, 1.4 Hz, 1H), 4.84 (d, J = 1.6 Hz, 1H), 4.13 (ddt, J = 13.0, 5.1, 1.6 Hz, 1H), 3.92 
(ddt, J = 13.0, 6.1, 1.4 Hz, 1H), 3.75 3.66 (br s, 1H), 3.56 (dq, J = 9.2, 6.2 Hz, 1H), 3.50 – 3.42 (br s, 
1H), 3.43 (dd, J = 3.8, 1.5 Hz, 1H), 3.41 (s, 3H), 3.33 (t, J = 9.5 Hz, 1H), 3.24 – 3.11 (m, 1H), 1.24 (d, 
J = 6.2 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 133.7, 117.2, 95.4, 80.4, 73.5, 71.4, 67.9, 
67.8, 58.8, 17.5 ppm. IR (film): ṽ = 3416, 2976, 2932, 2907, 2832, 1453, 1382, 1192, 1133, 1103, 
1075, 1038, 990, 975, 926, 912, 874, 836, 807 cm
-1
. MS (EI) m/z (%) = 157 (8), 156 (16), 129 (18), 
125 (7), 116 (28), 115 (8), 114 (17), 113 (15), 103 (5), 96 (13), 87 (22), 85 (13), 83 (12), 74 (50), 45 
(9), 43 (100), 41 (20). 
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Allyl 3,4-bis-O-acetyl-2-O-methyl-α-L-rhamnopyranoside (38). NEt3 (2.8 mL, 21 mmol) and Ac2O 
(1.4 mL, 21 mmol) were subsequently added via syringe at 0°C to a solution of 
DMAP (152 mg, 1.2 mmol) and the crude diol 37a (1.4 g, 6.2 mmol) in 
CH2Cl2 (40 mL). The ice bath was removed and stirring continued for 2 h at 
ambient temperature. Aq. sat. NH4Cl (20 mL) was added and the aqueous 
phase extracted with EtOAc (3 x 7 mL). The combined extracts were dried over Na2SO4 and 
concentrated. The residue was purified by flash chromatography (hexanes/EtOAc 3:2) to give the 
desired bisacetate as a white crystalline solid (1.28 g, 68%).      
  = 72.3 (c = 0.98, CH2Cl2). 
1
H 
NMR (400 MHz, CDCl3): δ = 5.86 (dddd, J = 17.3, 10.4, 6.1, 5.1 Hz, 1H), 5.27 (dq, J = 17.2, 1.6 Hz, 
1H), 5.22 – 5.15 (m, 2H), 5.07 (t, J = 9.9 Hz, 1H), 4.82 (d, J = 1.8 Hz, 1H), 4.15 (ddt, J = 12.9, 5.1, 
1.5 Hz, 1H), 3.96 (ddt, J = 12.9, 6.1, 1.3 Hz, 1H), 3.78 (dq, J = 9.6, 5.2 Hz, 1H), 3.59 (dd, J = 3.3, 1.9 
Hz, 1H), 3.43 (s, 3H), 2.03 (s, 3H), 1.99 (s, 3H), 1.16 (d, J = 6.3 Hz, 3H) ppm. 
13
C NMR (100 MHz, 
CDCl3): δ = 170.3, 169.8, 133.5, 117.5, 96.4, 78.4, 71.6, 71.5, 68.1, 66.4, 59.5, 20.9, 20.7, 17.4 ppm. 
IR (film): ṽ = 2924, 1740, 1455, 1370, 1239, 1219, 1107, 1074, 1036, 1000, 976, 915, 835, 798 cm-1. 
MS (EI) m/z (%) = 157 (8), 156 (16), 129 (18), 125 (7), 116 (28), 115 (8), 114 (17), 113 (15), 103 (5), 
96 (13), 87 (22), 85 (13), 83 (12), 74 (50), 45 (9), 43 (100), 41 (20). HRMS (ESIpos): calcd for 
C14H22O7Na: 325.1258; found: 325.1255. 
 
3,4-Bis-O-acetyl-2-O-methyl-α-L-rhamnopyranose (39). SeO2 (488 mg, 4.40 mmol) was added to a 
solution of compound 38 (1.20 g, 3.97 mmol) and AcOH (183 µL, 3.20 mmol) in 
1,4-dioxane (10 mL) and the resulting suspension was stirred at reflux 
temperature for 2 h. After cooling to room temperature, the mixture was 
neutralized with Et3N (0.44 mL) and concentrated under reduced pressure. The residue was purified by 
flash chromatography (hexanes/EtOAc 3:2) to give the desired hemiacetal as a white solid (0.891 g, 
86%).      
  = 42.3 (c = 0.94, CH2Cl2). 
1
H NMR (400 MHz, CDCl3, data of the major anomer only): 
δ = 5.26 – 5.17 (m, 2H), 5.05 (t, J = 9.9 Hz, 1H), 4.04 (dq, J = 9.8, 6.2 Hz, 1H), 3.66 (d, J = 3.8 Hz, 
1H), 3.61 (dd, J = 3.3, 1.8 Hz, 1H), 3.43 (s, 3H), 2.02 (s, 3H), 1.98 (s, 3H), 1.13 (d, J = 6.2 Hz, 3H) 
ppm. 
13
C NMR (100 MHz, CDCl3, data of the major anomer only): δ = 170.4, 170.0, 92.0, 78.6, 71.5, 
71.3, 66.3, 59.5, 20.9, 20.7, 17.4 ppm. IR (film): ṽ = 3453, 2923, 2854, 1741, 1456, 1373, 1243, 1225, 
1108, 1074, 1050, 916, 797 cm
-1
. MS (EI) m/z (%) = 156 (14), 129 (34), 116 (12), 115 (5), 114 (14), 
113 (7), 87 (54), 85 (6), 83 (7), 74 (56), 45 (7), 43 (100), 29 (6). HRMS (ESIpos): calcd for 
C11H18O7Na: 285.0945; found: 285.0947. 
 
Trichloroacetimidate 40. Cl3CCN (0.934 mL, 9.31 mmol) was added 
dropwise to a suspension of hemiacetal 39 (348 mg, 0.19 mmol) and Cs2CO3 
(86.7 mg, 0.039 mmol) in CH2Cl2 (7.0 mL). After stirring for 3 h at room 
temperature, the mixture was filtered and the filtrate was evaporated. The 
34 
residue was purified by flash chromatography (hexanes/EtOAc 4:1) to give the desired 
trichloroacetimidate as a white solid (532 mg, 98%).      
  = 59.9 (c = 1.06, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ = 8.62 (s, 1H), 6.25 (d, J = 2.0 Hz, 1H), 5.28 – 5.10 (m, 2H), 3.98 (dq, J = 9.0, 
6.3 Hz, 1H), 3.80 (dd, J = 3.0, 2.0 Hz, 1H), 3.48 (s, 3H), 2.04 (s, 3H), 2.01 (s, 3H), 1.20 (d, J = 6.3 Hz, 
3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 169.9, 169.3, 160.0, 94.6, 90.5, 76.1, 70.7, 70.2, 69.0, 
59.2, 20.5, 20.4, 17.2 ppm. IR (film): ṽ = 3332, 2988, 2922, 2851, 1741, 1673, 1448, 1368, 1279, 
1236, 1219, 1156, 1107, 1056, 1039, 968, 943, 926, 842, 831, 793, 734 cm
-1
. MS (EI) m/z (%) = 245 
(28), 184 (19), 143 (14), 142 (24), 129 (16), 125 (28), 116 (18), 113 (13), 87 (22), 74 (34), 43 (100). 
HMRS (ESIpos): calcd for C13H18O7NCl3Na: 428.0041; found: 428.0042. 
 
Diyne 41. A flame-dried Schlenk tube was charged with a solution of alcohol 30 (224 mg, 
0.318 mmol) in CH2Cl2 (1.8 mL) and a solution of acid 11 (142 mg, 0.350 mmol) in CH2Cl2 (0.3 mL). 
DMAP (194 mg, 1.59 mmol) and DCC (138 mg, 0.668 mmol) were introduced as solids and the 
resulting mixture was stirred at ambient temperature for 18 h. The white precipitate was filtered off 
through a short pad of Celite that was rinsed with CH2Cl2. The combined filtrates were concentrated 
and the residue purified by flash chromatography (hexanes/EtOAc 
24:1) to give the diyne as a mixture of ,- and ,-olefins (1.5:1, 
222 mg, 64%) as a white foam, along with recovered alcohol 30 
(63.1 mg, 28%) as a colorless oil.  
A solution of DBU (0.5 M in MeCN, 102 µL, 0.051 mmol) was 
added to a solution of this mixture of diynes (222 mg, 
0.203 mmol) in MeCN (25 mL) and the resulting solution was 
stirred at 50°C for 70 h. After cooling to ambient temperature, sat. 
NH4Cl solution (30 mL) containing 10 drops of 1 M HCl was added, the aqueous phase was extracted 
with EtOAc (4 x 30 mL), and the combined organic extracts were dried over Na2SO4 and concentrated. 
The residue was purified by flash chromatography (hexanes/EtOAc 24:1) to yield the desired ,-
olefin as a white foam (202 mg, 91%).      
  = 10.5 (c = 1.03, CHCl3). 
1
H NMR (400 MHz, CDCl3): 
δ = 7.66 – 7.57 (m, 8H), 7.47 – 7.25 (m, 12H), 6.85 (dt, J = 15.5, 7.2 Hz, 1H), 5.90 (dd, J = 15.9, 
7.9 Hz, 1H), 5.72 (dt, J = 15.6, 1.5 Hz, 1H), 5.36 (ddd, J = 15.9, 2.0, 0.1 Hz, 1H), 5.22 – 5.11 (m, 1H), 
3.79 (ddd, J = 7.9, 6.4, 3.3 Hz, 1H), 3.76 – 3.67 (m, 3H), 3.61 (dd, J = 10.6, 4.5 Hz, 1H), 3.57 (dd, J = 
10.5, 4.2 Hz, 1H), 3.33 (ddd, J = 11.4, 5.8, 5.8 Hz, 1H), 3.26 (dd, J = 11.6, 6.2, 6.1 Hz, 1H), 2.45 – 
2.19 (m, 4H), 2.11 – 2.01 (m, 2H), 1.96 – 1.87 (m, 2H), 1.90 (d, J = 2.1 Hz, 3H), 1.83 (t, J = 2.6 Hz, 
1H), 1.80 – 1.73 (dd, J = 11.7, 3.7 Hz, 3H), 1.61 (ddd, J = 13.8, 7.4, 7.2 Hz, 1H), 1.37 – 1.27 (m, 1H), 
1.23 – 1.07 (m, 3H), 1.01 (s, 9H), 1.00 (s, 9H), 0.95 (d, J = 6.6 Hz, 3H), 0.86 (s, 9H), 0.83 (d, J = 
7.0 Hz, 3H), 0.04 (s, 3H), 0.03 (s, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 166.6, 148.4, 144.7, 
136.0, 136.0, 135.9, 135.6, 135.6, 134.6, 134.0, 133.5, 133.4, 129.6, 129.3, 129.1, 127.6, 127.6, 127.3, 
127.1, 123.4, 108.3, 84.4, 81.7, 80.9, 79.3, 78.3, 74.1, 73.2, 72.3, 69.2, 68.6, 65.2, 42.3, 41.4, 41.3, 
35 
38.8, 35.1, 35.0, 34.6, 33.3, 27.2, 26.8, 25.8, 20.7, 19.8, 19.6, 19.2, 18.1, 3.2, 4.5, 4.5 ppm. IR 
(film): ṽ = 2956, 2930, 2856, 1720, 1656, 1472, 1462, 1427, 1376, 1361, 1257, 1175, 1111, 1071, 
1006, 836, 823, 776, 740, 701 cm
-1
. MS (ESIpos) m/z (%) = 1115.7 (100 (M+Na). HRMS (ESIpos): 
calcd for C67H92O7Si3Na: 1115.6043; found:1115.6049. 
 
Diyne (11-epi)-41. Prepared analogously from acid 11-epi-11 (34.9 mg, 85.8 µmol) and alcohol 30 
(55 mg, 78.0 µmol) as a white foam (1
st
 step: 61 mg, 71% yield, 
2
nd
 step: 56 mg, 92%).      
  = +32.5 (c = 0.72, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ = 7.67 – 7.58 (m, 8H), 7.44 – 7.25 (m, 12H), 
6.86 (dt, J = 15.6, 7.0 Hz, 1H), 5.81 (dd, J = 15.8, 8.7 Hz, 1H), 
5.73 (dt, J = 15.6, 1.5 Hz, 1H), 5.42 (dd, J = 15.7, 2.2 Hz, 1H), 
5.22 – 5.14 (m, 1H), 3.81 (ddd, J = 7.8, 6.6, 3.1 Hz, 1H), 3.77 – 
3.67 (m, 3H), 3.64 (dd, J = 10.7, 4.8 Hz, 1H), 3.58 (dd, J = 10.7, 
4.8 Hz, 1H), 3.37 – 3.28 (m, 1H), 3.27 – 3.18 (m, 1H), 2.51 – 2.34 
(m, 2H), 2.34 – 2.19 (m, 2H), 2.07 – 2.02 (m, 2H), 1.96 – 1.88 (m, 2H), 1.86 (d, J = 2.2 Hz, 3H), 1.83 
(t, J = 2.6 Hz, 1H), 1.81 – 1.67 (m, 3H), 1.54 (ddd, J = 14.0, 9.7, 4.2 Hz, 1H), 1.26 – 1.12 (m, 4H), 
1.02 (s, 9H), 1.01 (s, 9H), 0.94 (d, J = 6.7 Hz, 3H), 0.86 (s, 9H), 0.83 (d, J = 7.1 Hz, 3H), 0.04 (s, 3H), 
0.03 (s, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 166.5, 148.0, 144.7, 136.0, 135.9, 135.9, 135.6, 
135.5, 134.6, 133.9, 133.5, 133.4, 129.6, 129.3, 129.1, 127.6, 127.6, 127.3, 127.1, 123.3, 109.2, 84.3, 
81.6, 81.0, 79.3, 78.4, 74.0, 73.3, 72.3, 71.4, 69.2, 68.6, 65.2, 42.9, 41.9, 41.3, 38.8, 35.1, 35.0, 34.7, 
33.9, 27.2, 26.8, 25.8, 21.0, 20.7, 19.5, 19.2, 18.1, 14.8, 4.2, 4.5, 4.5 ppm. IR (film): ṽ = 2956, 
2930, 2856, 1721, 1472, 1462, 1428, 1361, 1258, 1112, 1075, 1006, 836, 776, 740, 702, 612 cm
-1
. MS 
(ESIpos) m/z (%) = 1115.7 (100 (M+Na). HRMS (ESIpos): calcd for C67H92O7Si3Na: 1115.6043; 
found:1115.6053. 
 
Macrocyclic Enyne 43. A flame-dried Schlenk tube was charged with powdered 4Å molecular sieves 
(~1.2 g) and 5Å molecular sieves (~1.5 g). The flask was then 
evacuated and the molecular sieves were flame-dried. After reaching 
ambient temperature, a solution of diyne 41 (191 mg, 0.175 mmol) in 
toluene (85 mL) was added and the resulting suspension was stirred 
for 45 min. In a separate flame-dried Schlenk tube, a stock solution of 
the molybdenum alkylidyne complex 42 (18.2 mg, 17.5 µmol) in 
toluene (2 mL) was prepared. This solution was added dropwise to the 
flask containing the diyne via syringe and the resulting mixture was 
stirred at ambient temperature for 3 h. The mixture was filtered through a short pad of Celite that was 
carefully rinsed with Et2O (100 mL). The combined filtrates were evaporated and the brown residue 
was purified by flash chromatography (hexanes/EtOAc 29:1 to 24:1 to 19:1) to yield the targeted 
36 
macrocyclic as a white foam (133 mg, 72%).      
  = 7.4 (c = 0.87, CHCl3). 
1
H NMR (400 MHz, 
CDCl3): δ = 7.68 – 7.60 (m, 8H), 7.45 – 7.24 (m, 12H), 6.87 (ddd, J = 15.7, 8.2, 5.7 Hz, 1H), 5.97 (dd, 
J = 16.0, 7.3 Hz, 1H), 5.73 (dt, J = 15.6, 1.3 Hz, 1H), 5.32 (dq, J = 15.9, 1.7 Hz, 1H), 5.22 – 5.15 (m, 
1H), 4.09 (ddd, J = 9.6, 5.7, 2.6 Hz, 1H), 3.82 – 3.74 (m, 2H), 3.74 – 3.69 (m, 1H), 3.67 (dd, J = 10.3, 
4.9 Hz, 1H), 3.62 (dd, J = 10.4, 5.0 Hz, 1H), 3.27 (dddd, J = 11.2, 9.2, 2.1, 1.8 Hz, 1H), 3.22 – 3.14 
(m, 1H), 2.31 (tdd, J = 9.1, 4.6, 1.5 Hz, 1H), 2.26 – 2.12 (m, 5H), 2.10 (dd, J = 14.2, 9.3, 2.5 Hz, 1H), 
1.86 – 1.67 (m, 4H), 1.61 – 1.50 (m, 1H), 1.35 – 1.30 (m, 2H), 1.22 – 1.11 (m, 2H), 1.03 (s, 9H), 1.01 
(s, 9H), 1.00 (d, J = 6.6 Hz, 3H), 0.92 (d, J = 6.9 Hz, 3H), 0.87 (s, 9H), 0.04 (s, 6H) ppm. 
13
C NMR 
(100 MHz, CDCl3): δ = 166.8, 148.5, 144.9, 135.9, 135.8, 135.6, 135.2, 135.0, 134.9, 133.9, 133.6, 
133.0, 129.5, 129.3, 129.2, 127.9, 127.6, 127.6, 127.4, 127.2, 123.6, 107.8, 86.8, 81.3, 81.2, 78.5, 
75.6, 74.5, 71.9, 71.7, 68.6, 65.5, 43.2, 42.2, 41.8, 38.4, 36.5, 35.1, 34.0, 33.8, 29.7, 27.2, 26.8, 25.8, 
21.6, 19.6, 19.3, 18.1, 13.8, 4.5 ppm. IR (film): ṽ = 2955, 2929, 2856, 1718, 1472, 1462, 1428, 1361, 
1328, 1256, 1174, 1112, 1071, 986, 836, 823, 775, 737, 700 cm
-1
. MS (ESIpos) m/z (%) = 1075.7 (100 
(M+Na). HRMS (ESIpos): calcd for C64H88O7Si3Na: 1075.5730; found:1075.5725. 
 
Macrocyclic Enyne (11-epi)-43. Prepared analogously from diyne 11-epi-41 (52 mg, 47.5 µmol) as a 
white foam (32 mg, 64%).      
  = +54.6 (c = 1.04, CH2Cl2). 
1
H NMR 
(400 MHz, CDCl3): δ = 7.69 (ddd, J = 7.7, 3.3, 1.7 Hz, 4H), 7.63 – 
7.56 (m, 4H), 7.44 – 7.25 (m, 12H), 6.97 (ddd, J = 15.4, 8.2, 7.0 Hz, 
1H), 5.73 (dt, J = 15.5, 1.1 Hz, 1H), 5.60 (dd, J = 15.7, 9.6 Hz, 1H), 
5.30 (dt, J = 15.7, 1.8 Hz, 1H), 5.09 – 5.02 (m, 1H), 4.16 (ddd, J = 8.8, 
6.8, 1.8 Hz, 1H), 3.85 (ddd, J = 8.2, 5.8, 3.9 Hz, 1H), 3.80 – 3.68 (m, 
2H), 3.65 (dd, J = 11.0, 3.4 Hz, 1H), 3.47 (dd, J = 11.0, 5.4 Hz, 1H), 
3.20 – 3.08 (m, 2H), 2.63 – 2.50 (m, 1H), 2.39 – 2.17 (m, 3H), 2.13 
(dd, J = 12.9, 7.9, 1H), 2.07 (ddd, J = 16.9, 5.7, 0.1 Hz, 1H), 1.90 (ddd, J = 14.5, 7.1, 2.1 Hz, 1H), 
1.80 – 1.64 (m, 4H), 1.59 – 1.51 (m, 1H), 1.51 – 1.41 (m, 1H), 1.30 – 1.14 (m, 3H), 1.02 (s, 9H), 1.01 
(m, 3H), 1.00 (s, 9H), 0.97 (d, J = 6.3 Hz, 3H), 0.86 (s, 9H), 0.03 (s, 6H) ppm. 
13
C NMR (100 MHz, 
CDCl3): δ = 165.3, 146.2, 146.0, 135.9, 135.9, 135.6, 134.8, 134.6, 133.6, 133.6, 129.5, 129.2, 129.1, 
127.6, 127.5, 127.3, 127.2, 123.3, 110.4, 86.6, 81.6, 81.0, 78.8, 75.5, 74.1, 72.9, 72.9, 68.7, 65.8, 42.6, 
42.2, 41.9, 38.6, 36.6, 35.8, 35.3, 33.8, 27.3, 26.8, 25.8, 23.1, 21.3, 19.7, 19.3, 18.1, 13.7, 4.5, 4.6 
ppm. IR (film): ṽ = 2955, 2930, 2857, 1722, 1472, 1462, 1428, 1361, 1327, 1257, 1176, 1112, 1067, 
854, 836, 823, 776, 739, 701, 608 cm
-1
. MS (ESIpos) m/z (%) = 1075.6 (100 (M+Na). HRMS 




Macrocyclic Diene 43a. In order to obtain reproducible results, all solvents used for the preparation 
of the activated Zn/Cu/Ag and the reaction were degassed by bubbling 
Ar through the solvent for at least 20 min. 
A Young tube was evacuated, backfilled with Argon and charged with 
a mixture of MeOH/H2O (1:1, 1.8 mL). Freshly prepared Zn/Cu/Ag
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(1.6 g) was added, followed by a solution of enyne 43 (130 mg, 
0.123 mmol) in THF (0.5 mL + 2 x 0.2 mL rinse). The Young tube was 
sealed and placed in a preheated (45°C) oil bath. The suspension was 
vigorously stirred at this temperature for 70 h before it was allowed to 
reach ambient temperature. The mixture was filtered through a short pad of Celite that was rinsed with 
EtOAc/EtOH (9:1, 75 mL). The combined filtrates were concentrated to 1/10 of the original volume 
before brine (10 mL) was added. The aqueous phase was extracted with EtOAc (3 x 10 mL) and the 
combined organic extracts were dried over Na2SO4 and concentrated. The residue was purified by 
flash chromatography (hexanes/EtOAc 29:1 to 24:1 to 19:1) to give the desired diene as a white foam 
(115 mg, 89%).      
  = 47.9 (c = 0.70, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 7.64 – 7.54 (m, 
8H), 7.40 – 7.22 (m, 12H), 6.84 (ddd, J = 15.7, 8.0, 5.5 Hz, 1H), 6.19 (dd, J = 15.4, 10.8 Hz, 1H), 5.88 
(t, J = 10.8 Hz, 1H), 5.76 (dt, J = 15.7, 1.4 Hz, 1H), 5.55 (dd, J = 15.4, 6.8 Hz, 1H), 5.18 – 5.08 (m, 
2H), 3.99 (ddd, J = 8.8, 6.0, 2.3 Hz, 1H), 3.73 (td, J = 7.9, 6.3 Hz, 1H), 3.66 (dt, J = 10.0, 4.8 Hz, 1H), 
3.64 – 3.59 (m, 2H), 3.56 (dt, J = 7.0, 5.7 Hz, 1H), 3.28 – 3.14 (m, 2H), 2.43 – 2.33 (m, 1H), 2.32 – 
2.24 (m, 1H), 2.20 (ddd, J = 16.0, 8.2, 2.7 Hz, 1H), 2.14 – 1.95 (m, 3H), 1.90 (dt, J = 15.7, 7.5 Hz, 
1H), 1.85 – 1.77 (m, 2H), 1.75 – 1.64 (m, 3H), 1.34 (ddd, J = 12.7, 7.3, 5.2 Hz, 1H), 1.29 – 1.25 (m, 
1H), 1.23 – 1.17 (m, 2H), 1.17 – 1.07 (m, 1H), 0.99 (s, 9H), 0.97 (s, 9H), 0.94 (d, J = 6. 7 Hz, 3H), 
0.83 (s, 9H), 0.76 (d, J = 7.1 Hz, 3H), 0.00 (s, 6H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 165.8, 
145.0, 140.2, 136.0, 136.0, 135.6, 135.6, 134.7, 133.9, 133.5, 133.5, 129.6, 129.5, 129.4, 127.6, 127.6, 
127.4, 127.2, 126.4, 124.3, 123.3, 81.4, 80.1, 74.2, 73.4, 72.0, 71.6, 68.7, 65.4, 43.1, 41.9, 41.9, 38.5, 
35.4, 34.4, 34.3, 32.1, 30.0, 27.2, 26.8, 25.8, 20.7, 19.5, 19.3, 18.1, 15.4, 4.5 ppm. IR (film): ṽ = 
2956, 2930, 2857, 1721, 1654, 1472, 1462, 1428, 1375, 1257, 1175, 1112, 1073, 1006, 836, 823, 775, 
739, 702 cm
-1
. MS (ESIpos) m/z (%) = 1077.6 (100 (M+Na)). HRMS (ESIpos): calcd for 
C64H90O7Si3Na: 1077.5887; found:1075.5884. 
 
Macrocyclic Diene (11-epi)-43a. Prepared analogously from enyne 
11-epi-43 (31.0 mg, 29.4 µmol) as a white foam (26.8 mg, 86%).      
  
= +15.2 (c = 1.22, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 7.66 – 
7.53 (m, 8H), 7.42 – 7.20 (m, 12H), 7.09 (ddd, J = 15.1, 10.3, 4.3 Hz, 
1H), 6.21 (dd, J = 14.9, 11.1 Hz, 1H), 5.89 (tt, J = 10.9, 1.9 Hz, 1H), 
5.74 (dd, J = 15.6, 1.6 Hz, 1H), 5.25 (dd, J = 14.9, 9.7 Hz, 1H), 5.12 – 
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5.02 (m, 2H), 3.92 – 3.82 (m, 2H), 3.77 – 3.65 (m, 2H), 3.41 (dd, J = 11.2, 3.3 Hz, 1H), 3.34 (dd, J = 
11.2, 5.3 Hz, 1H), 3.18 – 3.04 (m, 2H), 2.71 – 2.59 (m, 1H), 2.40 (tdd, J = 9.6, 4.6, 1.9 Hz, 1H), 2.26 – 
2.11 (m, 4H), 2.03 (dt, J = 15.1, 7.4 Hz, 1H), 1.93 (dt, J = 14.6, 5.9 Hz, 1H), 1.85 – 1.72 (m, 2H), 1.66 
(dd, J = 12.5, 4.7 Hz, 1H), 1.56 (ddd, J = 14.0, 10.6, 2.9 Hz, 2H), 1.49 – 1.38 (m, 1H), 1.25 – 1.12 (m, 
4H), 1.01 (s, 9H), 0.99 (d, J = 6.8 Hz, 3H), 0.97 (s, 9H), 0.85 (s, 9H), 0.79 (d, J = 7.0 Hz, 3H), 0.02 (s, 
3H), 0.02 (s, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 165.2, 145.7, 139.8, 135.9, 135.8, 135.7, 
135.6, 134.1, 133.9, 133.7, 133.4, 129.6, 129.5, 127.6, 127.5, 127.5, 127.4, 125.9, 125.6, 122.8, 81.3, 
80.7, 75.1, 73.0, 72.3, 72.0, 68.5, 65.1, 43.5, 42.3, 42.1, 39.3, 35.6, 34.6, 34.6, 33.9, 29.4, 27.1, 26.7, 
25.8, 22.1, 19.4, 19.2, 18.1, 15.1, 4.5, 4.5 ppm. IR (film): ṽ = 2957, 2928, 2856, 1724, 1427, 1257, 
1157, 1113, 1076, 833, 822, 778, 741, 703, 557 cm
-1
. MS (ESIpos) m/z (%) = 1077.6 (100 (M+Na)). 
HRMS (ESIpos): calcd for C64H90O7Si3Na: 1077.5887; found: 1077.5884. 
 
Alcohol 44. p-TsOH·H2O (6.2 mg, 32.6 µmol) was added to a solution of silyl ether 43a (114 mg, 
0.109 mmol) in CH2Cl2/MeOH (2:1, 12 mL) and the mixture was 
stirred for 5 h. The reaction was quenched by addition of sat. NaHCO3 
solution (12 mL) and the aqueous layer was extracted with CH2Cl2 (3 x 
8 mL). The combined extracts were dried over Na2SO4 and 
concentrated, and the residue was purified by flash chromatography 
(hexanes/EtOAc 2:1) to yield the desired alcohol as a white foam 
(92 mg, 90%).      
  = 42.5 (c = 0.89, CH2Cl2). 
1
H NMR (400 MHz, 
CDCl3): δ = 7.70 – 7.58 (m, 8H), 7.43 – 7.25 (m, 12H), 6.87 (ddd, J = 
15.8, 7.9, 5.7 Hz, 1H), 6.23 (ddt, J = 15.6, 10.8, 1.2 Hz, 1H), 5.92 (t, J = 10.8 Hz, 1H), 5.80 (dt, J = 
15.8, 1.4 Hz, 1H), 5.59 (dd, J = 15.4, 6.9 Hz, 1H), 5.23 – 5.12 (m, 2H), 4.03 (ddd, J = 8.8, 6.0, 2.3 Hz, 
1H), 3.83 – 3.71 (m, 2H), 3.71 – 3.56 (m, 3H), 3.35 – 3.21 (m, 2H), 2.46 – 2.30 (m, 2H), 2.27 (tdd, J = 
7.5, 3.0, 1.3 Hz, 1H), 2.18 – 2.05 (m, 2H), 2.03 (ddd, J = 14.5, 10.1, 0.1 Hz, 1H), 1.99 – 1.81 (m, 5H), 
1.76 (ddd, J = 14.0, 8.2, 6.0 Hz, 1H), 1.52 – 1.44 (br s, 1H), 1.38 (ddd, J = 12.8, 7.3, 5.4 Hz, 1H), 1.33 
(ddd, J = 13.5, 8.1, 4.8 Hz, 1H), 1.22 (ddd, J = 11.5, 10.9, 10.6 Hz, 1H), 1.13 (ddd, J = 11.6, 11.3, 
1.09 Hz, 1H), 1.03 (s, 9H), 1.01 (s, 9H), 0.98 (d, J = 6.7 Hz, 3H), 0.80 (d, J = 7.0 Hz, 3H) ppm. 
13
C 
NMR (100 MHz, CDCl3): δ = 165.7, 143.7, 140.0, 136.0, 136.0, 135.6, 135.6, 134.6, 133.9, 133.5, 
130.0, 129.6, 129.6, 129.4, 129.2, 127.6, 127.6, 127.4, 127.2, 126.4, 124.4, 123.3, 81.4, 80.1, 74.2, 
73.4, 72.1, 71.6, 68.1, 65.4, 42.9, 41.4, 41.3, 38.4, 35.4, 34.5, 34.3, 32.1, 30.0, 27.2, 26.8, 20.9, 19.5, 
15.4 ppm. IR (film): ṽ = 3454, 2957, 2930, 2857, 1720, 1654, 1472, 1427, 1361, 1265, 1176, 1112, 
1006, 822, 739, 702 cm
-1
. MS (ESIpos) m/z (%) = 963.6 (100 (M+Na). HRMS (ESIpos): calcd for 




Alcohol (11-epi)-44. Prepared analogously from silyl ether 11-epi-43a (24.2 mg, 22.9 µmol) as a 
white foam (19.3 mg, 89%).      
  = +28.4 (c = 0.96, CH2Cl2). 
1
H 
NMR (400 MHz, CDCl3): δ = 7.66 – 7.53 (m, 8H), 7.42 – 7.20 (m, 
12H), 7.07 (ddd, J = 15.1, 10.2, 4.4 Hz, 1H), 6.20 (dd, J = 14.9, 
11.0 Hz, 1H), 5.87 (tt, J = 10.9, 1.9 Hz, 1H), 5.75 (dd, J = 15.6, 1.7 Hz, 
1H), 5.24 (dd, J = 14.9, 9.7 Hz, 1H), 5.11 – 5.01 (m, 2H), 3.93 – 3.83 
(m, 2H), 3.79 – 3.68 (m, 2H), 3.41 (dd, J = 11.1, 3.5 Hz, 1H), 3.35 (dd, 
J = 11.2, 5.3 Hz, 1H), 3.21 – 3.07 (m, 2H), 2.64 (tt, J = 9.5, 3.4 Hz, 
1H), 2.42 (tdd, J = 9.6, 4.7, 1.9 Hz, 1H), 2.27 – 2.10 (m, 4H), 2.02 (dd, 
J = 8.0, 7.7, 7.4 Hz, 1H), 1.96 – 1.86 (m, 2H), 1.84 – 1.75 (m, 2H), 1.63 – 1.52 (m, 2H), 1.42 (ddd, J = 
13.6, 7.2, 3.5 Hz, 1H), 1.23 – 1.11 (m, 3H), 1.01 (s, 9H), 0.99 (d, J = 6.8 Hz, 3H), 0.97 (s, 9H), 0.78 
(d, J = 7.0 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 165.2, 145.4, 139.6, 135.9, 135.8, 135.7, 
135.6, 134.1, 133.9, 133.6, 133.5, 129.6, 129.5, 127.6, 127.5, 127.5, 127.4, 126.0, 125.7, 122.9, 81.3, 
80.8, 75.0, 73.1, 72.4, 72.1, 68.0, 65.2, 43.4, 41.7, 41.6, 39.2, 35.6, 34.6, 34.6, 34.0, 29.5, 27.1, 26.7, 
20.1, 19.4, 19.2, 15.1 ppm. IR (film): ṽ = 3414, 2957, 2930, 2857, 1722, 1655, 1472, 1428, 1361, 
1326, 1262, 1177, 1111, 990, 822, 739, 702, 610 cm
-1
. MS (ESIpos) m/z (%) = 963.6 (100 (M+Na)). 
HRMS (ESIpos): calcd for C58H76O7Si2Na: 963.5022; found: 963.5017. 
 
Glycoside 45. A Schlenk tube was charged with powdered 4Å MS (400 mg) that was flame-dried in 
vacuo. After reaching RT, the molecular sieves were suspended in 
CH2Cl2 (10 mL) and a solution of alcohol 44 (87.0 mg, 92.4 µmol) in 
CH2Cl2 (1.6 mL) was introduced. Rhamnosyl donor 40 (56.3 mg, 
139 µmol) was added as a solid and the resulting suspension was 
stirred for 45 min at ambient temperature before it was cooled to 
50°C. A solution of TESOTf (0.1 M, 277 µL, 27.7 µmol) was added 
dropwise via syringe over 1 min. After stirring for 30 min at 50°C, 
the reaction was quenched with NEt3 (0.1 mL), the mixture was 
filtered through a pad of Celite and the filtrate was evaporated. The 
crude residue was purified by flash chromatography (hexanes/EtOAc 
3:1) to yield the desired glycoside as a white foam (97.0 mg, 88% yield, 16:1 d.r.).      
  = 61.5 (c = 
0.82, CHCl3). 
1
H NMR (600 MHz, CDCl3): δ = 7.70 – 7.55 (m, 8H), 7.43 – 7.24 (m, 12H), 6.85 (ddd, 
J = 15.8, 8.1, 5.5 Hz, 1H), 6.23 (dd, J = 15.4, 10.8 Hz, 1H), 5.91 (t, J = 10.8 Hz, 1H), 5.80 (dt, J = 
15.7, 1.1 Hz, 1H), 5.58 (dd, J = 15.4, 6.8 Hz, 1H), 5.23 – 5.14 (m, 3H), 5.08 (t, J = 9.9 Hz, 1H), 4.95 
(d, J = 1.9 Hz, 1H), 4.02 (ddd, J = 8.8, 6.1, 2.4 Hz, 1H), 3.82 (dq, J = 9.7, 6.3 Hz, 1H), 3.79 – 3.70 (m, 
2H), 3.65 (dd, J = 10.7, 4.5 Hz, 2H), 3.60 (q, J = 6.4 Hz, 1H), 3.54 (dd, J = 3.3, 1.8 Hz, 1H), 3.45 (s, 
3H), 3.32 – 3.23 (m, 2H), 2.44 – 2.37 (m, 1H), 2.37 – 2.31 (m, 1H), 2.25 (ddd, J = 15.3, 8.1, 2.6 Hz, 
1H), 2.14 – 2.06 (m, 2H), 2.05 (s, 3H), 2.03 – 1.99 (m, 1H), 2.00 (s, 3H), 1.98 – 1.90 (m, 2H), 1.90 – 
40 
1.81 (m, 3H), 1.75 (ddd, J = 14.1, 8.5, 6.0 Hz, 1H), 1.37 (ddd, J = 12.7, 7.3, 5.1 Hz, 1H), 1.34 – 1.28 
(m, 2H), 1.27 – 1.26 (m, 1H), 1.17 (d, J = 6.3 Hz, 3H), 1.02 (s, 9H), 1.00 (s, 9H), 0.98 (d, J = 6.7 Hz, 
3H), 0.79 (d, J = 7.1 Hz, 3H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 170.3, 169.9, 165.7, 144.5, 
140.0, 136.0, 136.0, 135.6, 135.6, 135.6, 134.6, 133.9, 133.5, 130.0, 129.6, 129.6, 129.4, 129.2, 127.6, 
127.6, 127.4, 127.2, 126.5, 124.4, 123.5, 95.4, 81.4, 80.1, 78.8, 74.1, 73.4, 73.2, 72.1, 71.7, 71.6, 71.6, 
66.7, 65.4, 59.6, 43.0, 39.1, 38.5, 37.6, 35.4, 34.5, 34.3, 32.1, 29.9, 29.7, 27.2, 26.8, 21.0, 20.8, 19.5, 
19.3, 17.5, 15.3 ppm. IR (film): ṽ = 2958, 2929, 2857, 1745, 1720, 1654, 1472, 1361, 1427, 1365, 
1241, 1223, 1177, 1107, 1074, 1040, 998, 822, 803, 755, 702 cm
-1
. MS (ESIpos) m/z (%) = 1207.6 
(100 (M+Na)). HRMS (ESIpos): calcd for C69H92O13Si2Na: 1207.5969; found: 107.5976. 
 
Glycoside (11-epi)-45. Prepared analogously from 11-epi-44 (24.2 mg, 22.9 µmol) as a white foam 
(20.6 mg, 87% yield, single dr).      
  = 17.4 (c = 0.87, CH2Cl2). 
1
H NMR (400 MHz, CDCl3): δ = 7.67 – 7.52 (m, 8H), 7.43 – 7.24 
(m, 11H), 7.23 – 7.20 (m, 1H), 7.05 (ddd, J = 15.2, 10.3, 4.4 Hz, 
1H), 6.19 (dd, J = 14.9, 11.0 Hz, 1H), 5.87 (t, J = 11.0 Hz, 1H), 5.74 
(dd, J = 15.6, 1.1 Hz, 1H), 5.24 (dd, J = 15.0 Hz, 9.7 Hz, 1H), 5.18 
(dd, J = 10.1, 3.2 Hz, 1H), 5.12 – 5.00 (m, 3H), 4.91 (d, J = 1.9 Hz, 
1H), 3.92 – 3.83 (m, 2H), 3.80 (dq, J = 9.5, 6.2 Hz, 1H), 3.77 – 3.66 
(m, 2H), 3.52 (dd, J = 3.18, 1.98 Hz, 1H), 3.43 (s, 3H), 3.40 (dd, J = 
11.1, 3.5 Hz, 1H), 3.35 (dd, J = 11.2, 5.1 Hz, 1H), 3.21 – 3.06 (m, 
2H), 2.69 – 2.56 (m, 1H), 2.43 (dddd, J = 14.1, 9.3, 4.3, 1.5 Hz, 1H), 
2.25 – 2.17 (m, 2H), 2.17 – 2.10 (m, 2H), 2.04 (s, 3H), 2.01 (s, 3H), 1.96 – 1.87 (m, 2H), 1.83 – 1.74 
(m, 2H), 1.56 (dd, J = 14.0, 2.8 Hz, 1H), 1.45 – 1.37 (m, 1H), 1.31 (q, J = 11.7 Hz, 2H), 1.23 – 1.16 
(m, 2H), 1.15 (d, J = 6.2 Hz, 3H), 1.00 (s, 9H), 0.98 (d, J = 6.6 Hz, 3H), 0.96 (s, 9H), 0.78 (d, J = 
7.0 Hz, 3H) ppm. 
13
C NMR (100 MHz, CDCl3): δ = 170.3, 169.9, 165.2, 145.3, 139.5, 135.9, 135.8, 
135.6, 135.6, 134.1, 133.9, 133.6, 133.4, 129.6, 129.5, 129.5, 127.6, 127.5, 127.5, 127.4, 126.0, 125.7, 
123.0, 95.4, 81.3, 80.8, 78.8, 75.0, 73.1, 73.1, 72.4, 72.1, 71.6, 71.6, 66.6, 65.1, 59.6, 43.4, 39.3, 39.3, 
37.9, 35.6, 34.6, 33.9, 29.4, 27.0, 26.7, 22.0, 21.0, 20.8, 19.4, 19.2, 17.4, 15.1 ppm. IR (film): ṽ = 
2956, 2930, 2857, 1725, 1428, 1365, 1327, 1243, 1223, 1178, 1110, 1042, 912, 824, 736, 703, 611 cm
-
1
. MS (ESIpos) m/z (%) = 1207.6 (100 (M+Na)). HRMS (ESIpos): calcd for C69H92O13Si2Na: 




Diol 45a. Dry K2CO3 (28.3 mg, 205 µmol) was added to a solution of compound 45 (96.9 mg, 
81.8 µmol) in MeOH (11 mL) at 0°C. The mixture was stirred at this 
temperature for 2 h before a second portion of K2CO3 (22.6 mg, 
164 µmol) was introduced. After an additonal 2 h at 0°C, the reaction 
was quenched with NH4Cl solution (15 mL) and the mixture allowed 
to reach ambient temperature. The aqueous phase was extracted with 
EtOAc (4 x 15 mL) and the combined organic extracts were dried 
over Na2SO4 and concentrated. The residue was purified by flash 
chromatography (hexanes/EtOAc 2:3) to give the desired product as 
a white foam (72.3 mg, 80%).      
  = 53.1 (c = 0.57, CHCl3). 
1
H 
NMR (600 MHz, CDCl3): δ = 7.66 – 7.59 (m, 8H), 7.41 – 7.25 (m, 
12H), 6.86 (ddd, J = 15.8, 8.2, 5.6 Hz, 1H), 6.22 (ddt, J = 15.5, 10.8, 1.2 Hz, 1H), 5.91 (t, J = 10.8 Hz, 
1H), 5.80 (dt, J = 15.7, 1.4 Hz, 1H), 5.59 (dd, J = 15.4, 6.8 Hz, 1H), 5.21 – 5.09 (m, 2H), 5.02 (d, J = 
1.5 Hz, 1H), 4.02 (ddd, J = 8.9, 6.2, 2.3 Hz, 1H), 3.80 – 3.72 (m, 2H), 3.69 (td, J = 9.6, 3.7 Hz, 1H), 
3.69 – 3.65 (m, 2H), 3.64 – 3.58 (m, 2H), 3.45 (s, 3H), 3.40 (dd, J = 3.8, 1.5 Hz, 1H), 3.36 (dd, J = 
9.6, 9.4 Hz, 1H), 3.35 – 3.25 (m, 2H), 2.45 – 2.39 (m, 1H), 2.38 – 2.31 (m, 2H), 2.31 – 2.23 (m, 2H), 
2.13 – 2.06 (m, 2H), 2.02 (ddd, J = 14.9, 10.1, 2.5 Hz, 1H), 1.97 – 1.90 (m, 2H), 1.90 – 1.82 (m, 3H), 
1.75 (ddd, J = 14.0, 8.4, 5.9 Hz, 1H), 1.37 (ddd, J = 12.8, 7.4, 5.3 Hz, 1H), 1.32 (ddd, J = 13.7, 8.0, 4.2 
Hz, 1H), 1.28 (d, J = 6.2 Hz, 3H), 1.24 – 1.17 (m, 2H), 1.03 (s, 9H), 1.00 (s, 9H), 0.98 (d, J = 6.7 Hz, 
3H), 0.79 (d, J = 7.0 Hz, 3H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 165.7, 144.5, 140.0, 136.0, 
136.0, 135.6, 135.6, 135.5, 134.6, 134.0, 133.5, 130.0, 129.6, 129.6, 129.3, 129.2, 127.6, 127.6, 127.4, 
127.2, 126.5, 124.4, 123.5, 93.9, 81.4, 80.6, 80.1, 74.0, 74.0, 73.5, 72.7, 72.1, 71.7, 71.4, 67.9, 65.4, 
58.9, 43.0, 39.1, 38.5, 37.5, 35.4, 34.5, 34.4, 29.9, 27.2, 26.8, 20.8, 19.5, 19.3, 17.5, 15.4 ppm. IR 
(film): ṽ = 3411, 2958, 2930, 2857, 1719, 1656, 1462, 1428, 1360, 1327, 1263, 1176, 1111, 1076, 
1045, 823, 740, 702 cm
-1
. MS (ESIpos) m/z (%) = 1123.7 (100 (M+Na)). HRMS (ESIpos): calcd for 
C65H88O11Si2Na: 1123.5757; found: 1123.5748. 
 
Diol (11-epi)-45a. Prepared analogously from alcohol 11-epi-45 
(20.0 mg, 16.9 µmol) as a white foam (16.4 mg, 88%).      
  = 5.9 
(c = 0.67, CH2Cl2). 
1
H NMR (600 MHz, CDCl3): δ = 7.65 – 7.53 (m, 
8H), 7.42 – 7.24 (m, 10H), 7.24 – 7.19 (m, 2H), 7.05 (ddd, J = 15.5, 
10.3, 4.3 Hz, 1H), 6.20 (dd, J = 15.0, 11.0 Hz, 1H), 5.88 (tt, J = 11.0, 
1.9 Hz, 1H), 5.77 – 5.71 (m, 1H), 5.25 (dd, J = 14.9, 9.7 Hz, 1H), 
5.11 – 5.00 (m, 2H), 4.97 (d, J = 1.4 Hz, 1H), 3.91 – 3.83 (m, 2H), 
3.76 – 3.69 (m, 2H), 3.67 (dd, J = 9.4, 3.8 Hz, 1H), 3.61 (dq, J = 9.4, 
6.2 Hz, 1H), 3.42 (s, 3H), 3.40 – 3.33 (m, 3H), 3.32 (dd, J = 9.3, 
9.3 Hz, 1H), 3.17 (tt, J = 11.3, 1.9 Hz, 1H), 3.11 (tdd, J = 11.2, 3.3, 
42 
1.8 Hz, 1H) 2.70 – 2.57 (m, 1H), 2.43 (dddd, J = 14.4, 9.2, 4.3, 1.9 Hz, 1H), 2.36 – 2.28 (br s, 1H), 
2.23 – 2.17 (m, 2H), 2.18 – 2.11 (m, 2H), 2.03 (dt, J = 13.1, 7.6 Hz, 1H), 1.97 – 1.88 (m, 2H), 1.83 – 
1.75 (m, 2H), 1.56 (ddd, J = 14.1, 11.1, 3.1 Hz, 1H), 1.41 (ddd, J = 13.6, 7.7, 5.9 Hz, 1H), 1.31 – 1.22 
(m, 2H), 1.26 (d, J = 6.1 Hz, 3H), 1.22 – 1.10 (m, 2H), 1.00 (s, 9H), 0.99 (d, J = 6.5 Hz, 3H), 0.97 (s, 
9H), 0.78 (d, J = 7.0 Hz, 3H) ppm. 
13
C NMR (150 MHz, CDCl3): δ = 165.2, 145.3, 139.6, 135.9, 
135.8, 135.7, 135.6, 134.1, 133.9, 133.6, 133.4, 129.6, 129.5, 129.5, 129.5, 127.6, 127.5, 127.5, 127.4, 
126.0, 125.7, 123.0, 93.9, 81.3, 80.7, 80.6, 74.9, 74.0, 73.1, 72.6, 72.4, 72.1, 71.4, 67.8, 65.1, 58.8, 
43.4, 39.3, 37.9, 35.6, 34.6, 34.6, 33.9, 29.4, 27.0, 26.7, 22.0, 19.4, 19.2, 17.5, 15.2 ppm. IR (film): ṽ = 
3426, 2956, 2929, 2857, 1722, 1461, 1428, 1390, 1361, 1326, 1261, 1178, 1108, 1077, 1043, 909, 
822, 734, 702, 611 cm
-1
. MS (ESIpos) m/z (%) = 1123.6 (100 (M+Na)). HRMS (ESIpos): calcd for 
C65H88O11Si2Na: 1123.5757; found: 1123.5754. 
 
Putative Mandelalide A (1). A Teflon vial was charged with diol 45a (42.0 mg, 38.1 µmol) and THF 
(2.5 mL). The solution was cooled to 0°C before pyridine (2.5 mL) and 
HF·pyridine (2.5 mL) were slowly added via an Eppendorf pipette. After 
stirring for 5 min at 0°C, the ice bath was removed and stirring 
continued at ambient temperature for 46 h. The mixture was diluted with 
EtOAc (10 mL) and carefully poured into NaHCO3 solution (30 mL). 
The aqueous phase was extracted with EtOAc/EtOH (9:1, 4 x 15 mL). 
The combined organic extracts were washed with NH4Cl solution 
(20 mL), dried over Na2SO4 and concentrated. The residue was purified 
by flash chromatography (CH2Cl2/MeOH 97:3 to 96:4 to 95:5 to 96:4) to 
give the desired compound as a white amorphous solid (19.1 mg, 80%). 
     
  = 29 (c = 0.25, MeOH). 1H NMR (600 MHz, CDCl3): see Table 3. 
13
C NMR (150 MHz, 
CDCl3): see Table 3. IR (film): ṽ = 3427, 2924, 1714, 1653, 1454, 1373, 1323, 1275, 1179, 1106, 
1043, 988, 734 cm
-1
. MS (ESIpos) m/z (%) = 647.4 (100 (M+Na)). HRMS (ESIpos): calcd for 
C33H52O11Na: 647.3402; found: 647.3406.  
 
 (11-epi)-Isomer of putative Mandelalide A (11-epi-1). Prepared 
analogously from diol 11-epi-45a (10.0 mg, 9.08 µmol) as a white 
amorphous solid (4.8 mg, 85%).      
  = 25.8 (c = 0.41, MeOH). 1H 
NMR (600 MHz, CDCl3): see Table 4. 
13
C NMR (150 MHz, CDCl3): see 
Table 4. IR (film): ṽ = 3411, 2924, 2854, 1716, 1654, 1457, 1373, 1246, 
1178, 1107, 1045, 992, 812, 733 cm
-1
. MS (ESIpos) m/z (%) = 647.4 







The following Scheme shows key NOESY contacts observed for 1 and 11-epi-1. The structural 
assignments made above for the different building blocks were confirmed by the observed NOE 
contacts between H5, H7 and H9 for the southern THP unit. Furthermore, the NOE contacts between 
H17, H18 and H19 indicates once again an all-cis configured THF ring. Interesting to note are the 







For comparison with the natural product, the 
13
C NMR spectra of synthetic 1 and 11-epi-1 were 
referenced to CDCl3 = 77.23 ppm as in the isolation paper (in other spectra reported above, the solvent 








C NMR data of putative Mandelalide A (1) (
1
H NMR: 600 MHz, 
13
C NMR: 











m J/Hz COSY HMBC NOESY 
1 -- 167.3 - - - - - 
2 5.92 123.1 dt 15.6, 1.5 3, (4ab) 1, (3), 4 3, 4(a)b, (25) 
3 7.02 146.3 ddd 15.5, 8.6, 5.5 2, 4a(b) 1, 2, 4, 5 2, 4a(b), (6a) 
4a 2.34 38.5 ddd 15.2, 6.5, 5.6, 1.8 (3), 4b, 5 2, 3, 5, 6 (2), 3, 4b, 5 
4b 2.46 -- dddd 15.2, 8.6, 3.7, 1.2 3, 4a, (5) 2, 3, 5, (6) 2, 3, 4a, 5, 25 
5 3.42 73.4 m - 4a(b), 6a 3, (4), 7, 9 (3), 4ab, 6b, 7, 9 
6a 1.26 36.7 m - 5, 6b, 7 5, 7, 8 - 
6b 1.94 -- ddt 12.0, 4.6, 1.9 6a, 7 6, 8 (5), 6a, 7, 1' 
7 3.77 72.8 m - 6ab, 8ab 6, 8, (1') 5, 6b, 8b, 9, 1' 
8a 1.22 39.3 m - 7, 8b, 9 - - 
8b 1.84 -- dddd 12.5, 4.2, 1.9, 1.9 7, 8a, (9) 6, 7, 9 7, 8a, 9 
9 3.33 73.1 m - 8a(b), 10ab (5), (7), 8, 10 5, 7, 8b, 10b, 25 
10a 1.27 42.9 m - 9, 10b, 11 - - 
10b 1.69 -- ddd 14.1, 9.1, 5.1 9, 10a, (11) 8, 9, 11, 12, 25 9, 10a 
11 2.44 32.8 m - 10a(b), 12, 25 9, 10, 12, 13, 25 9, 10a, 12, 13, 25 
12 5.61 140.9 dd 15.2, 7.6 11, 13 10, 11, 14, (15), 25 (10ab), 11, 13, 14, 25 
13 6.22 123.8 ddt 15.2, 10.8, 1.0 12, 14 11, 14, 15 11, 12, 14, 16ab, 25 
14 6.01 130.5 tt 10.8, 1.8 13, 15 12, 13, 16 12, 13, 15 
15 5.27 126.5 ddd 10.8, 8.3, 7.5 14, 16ab 13, 16, 17 14, 16ab, 17, (26) 
16a 2.14 
31.2 
Dddd 14.8, 6.8, 5.1, 1.9 15, 16b, 17 14, 15, 17, 18 
13, (15), 16a, (17), 
(26) 
16b 2.29 -- dtd 14.8, 8.5, 1.6 15, 16a, 17 (13), 14, 15, 17, 18 13, 15, 16b, 17, 26 
17 4.03 
81.3 
ddd 8.6, 7.2, 4.9 16ab, 18 15, 19, 20, 26 
15, 16a(b), 18, (20), 
(26) 
18 2.43 37.1 m - 17, 19a(b), 26 16, 17, 19, (20), 26 17, 19ab, 20, 26 
19a 1.28 36.0 m - 18, 19b, 20 - (18), 19b, 21, 26 
19b 2.04 -- dt 12.3, 6.7 (18), 19a, 20 17, 18, (20), 21, 26 18, 19a, 20, (26) 
20 3.71 
82.7 
ddd 8.4, 8.2, 6.7 19ab, 21 (17), (18), 19, 21, 22 




m - 20, 22(a)b (19), 20, 22, 23 
(16a), 19a, 20, 22b, 
23, 25, 26 
22a 1.54 34.1 ddd 14.4, 10.5, 2.5 21, 22b, (23) 20, 23, 24 20, 21, 22b, 23, 24ab 
22b 1.77 
-- 
ddd 14.4, 10.8, 2.0 (21), 22a, 23 (20), 23, 24 
(19b), 21, 22a, 23, 
(24a) 
23 5.24 72.5 m - 22(a)b, 24ab (22), (1) 21, 22a(b), 24ab 
24a 3.65 65.7 m - 23, 24b 22, 23 (22ab), 23, 24b 
24b 3.78 -- dd 12.1, 3.3 23, 24a 22, (23) 21, 23, 24a 
25 1.00 
20.1 
d 6.7 11 10, 11, 12 
9, (10b), 11, 12, 13, 
,21 ,2 
26 0.98 14.7 d 7.0 18 17, 18, 19 16a(b), (17), 18, (21) 
1' 5.02 94.0 d 1.5 2' 7, 2', 3', 5' 6b, 7, 2', 7' 
2' 3.40 80.9 dd 3.8, 1.5 1', 3' 3', 4', 7' 1', 7', 3' 
3' 3.69 71.7 m - 2', 4' (2'), 4' (2'), 5' 
4' 3.34 74.2 t 9.4 3', 5' 3', 5' 6', 7' 
5' 3.63 68.2 dd 9.4, 6.1 4', 6' (1'), 3', 4', (6') (2'), 3', 6' 
6' 1.28 17.7 d 6.3 5' (1'), 4', 5' 4', 5', 7' 
7' 3.46 59.2 s - - 2' 1', 6' 
OHa 2.56-2.33 - - - 21 21,22  
OHb 2.56-2.33 - - -    
OHc 2.44-2.34 - - - 3' 3'  
OHd 2.78-2.64 - br s - 4' 4'  
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 The assignment of multiple protons on a single carbon (e.g. 4a and 4b) is in analogy to the ones reported in the 
























m J/Hz COSY HMBC NOESY 
1 -- 166.8 - - - - - 
2 5.92 123.6 dt 15.6, 1.1 3, (4a) 1, 3, 4, (5) 3, 4b 
3 7.09 146.1 ddd 15.6, 8.2, 6.7 2, 4ab 1, 2, 4, 5 2, 4ab, 5, 11, 13, (21) 
4a 2.31 39.5 dddd 14.3, 8.2, 2.7, 0.8 3, 4b, (5) 2, 3, 5, (6) 2, 3, 4b, 5, (6a) 
4b 2.39 - m - 3, 4a, 5 2, 3, 5, 6 2, 3, 4b, 6a 
5 3.26 74.0 dddd 11.2, 10.5, 3.0, 2.1 4a, 4b, 6a(b) (3), (4), (9) 4a, 6b, 7, 9 
6a 1.15 38.2 ddd 11.8, 11.7, 11.6 5, 6b, 7 5, 7, 8 4b, 6b, 8a 
6b 1.98 - ddt 12.2, 4.7, 1.9 5, 6a, 7 (5), 7, 8 4a, 5, 6a, 7, 1' 
7 3.76 72.7 m - 6a(b), 8a(b) 8, (9), 1' 5, 6b, 8b, 9, 1' 
8a 1.27 39.2 m - 7, 8b, 9 6, 7, 9, 10 6a, 8b 
8b 1.75 - ddt 12.4, 4.7, 1.9, 1.7 7, 8a, (9) 6, 7, 9 7, 8a, 9, 10a 
9 3.16 73.2 tt 11.1, 1.5 8a, 10(a)b 5, 7, 10, 11 5, 7, 8b, 10a 
10a 1.14 43.5 m - (9), 10b, 11 (5), 7, 8, 11, 12, 25 8b, 9, 10b, (12), (25) 
10b 1.52 - ddd 13.9, 11.0, 2.8 9, (11), 10a 9, 11, 12, 25 (8a), 10a, 11, 25 
11 2.48 34.1 m - 10a, 12, 25 9, 10, 12, 13, (25) 9, 10b, (12), 13, 25 
12 5.32 141.3 dd 14.9, 9.7 11, 13 10, 11, 14, 25 (9), 10a, (11), 13, 14, 25 
13 6.10 124.9 dd 14.9, 11.0 12, 14 11, 14, 15 (3), 11, 12, 16(a)b, (21) 
14 6.00 130.6 ddt 11.0, 10.9, 1.5 (10ab), 13, 15 12, 13, 16 12, 15, 16b 
15 5.20 126.2 m - 14, 16ab 13, 16, 17 13, 14, 16ab, 17, 26 
16a 2.08 31.0 ddd 14.6, 5.9, 1.9 15, 16b, 17 (13), 14, 15, 17, 18 13, 15, 16b, 17, 21, 26 
16b 2.25 - dddd 14.7, 9.0, 7.5, 1.4 
(14), 15, 16a, 
17 
14, 15, 17, 18 
13, (14), 15, 16a, 17, 19a, 
26 
17 3.99 81.8 dt 7.3, 6.2 18, 16ab 15, 19, 20, 26 16ab, 18, 20, (26) 
18 2.46 36.9 m - 17, 19ab, 26 16, 17, 20, 26 (15), 17, 19(a)b, 20, 26 
19a 1.26 36.4 m - 18, 19b, 20 18, (20), 21, 26 (18), 19b, 26 
19b 2.09 - ddd 12.3, 7.1, 7.1 (18), 19a, 20 18, 20, 21, 26 18, 19a, 20, 21 
20 3.74 82.1 m - 19ab, 21 17, 19, 21, 22 17, 18, 19(a)b, 21, (22b) 
21 3.46 73.3 dddd 9.1, 7.6, 2.8, 1.6 20, 22ab, OH1 20, 22, 23 
(3), 19a, 20, 22ab, 23, 
(26), OH1 
22a 1.55 34.7 ddd 14.7, 9.2, 2.1 21, 22b, (23) 20, 21, 24 21, 22b, 24ab 
22b 1.88 - dddt 14.4, 11.5, 1.4 21, 22a, 23 20, 23, 24 19a(b), 21, 22a, 24ab 
23 5.23 73.9 dddd 11.2, 5.3, 2.8, 2.7 22(a)b, 24ab (1), 22 21, 22ab, 24ab 
24a 3.65 65.7 m - 23, 24b 22, 23 22ab, 23, 24b 
24b 3.79 - m - 23, 24a 22, 23 22a(b), 23, 24a 
25 0.98 22.0 d 6.8 11 10, 11, 12 10ab, 11, 12 
26 0.98 14.9 d 7.0 18 17, 18, 19 16a(b), (15), (17), 18 
1' 4.99 94.1 d 1.2 2' 2', 3', 5', 7 2', 7', 6b, 7 
2' 3.38 80.9 dd 3.8, 1.5 1', 3' 3', 4', 7' 1', 3', 7' 
3' 3.68 71.6 td 9.7, 3.8 2', 4', OH3 1', 4' 2', 5', OH3, OH4 
4' 3.33 74.2 td 9.5, 1.9 3', 5', OH4 3', 5', 6', 7' 5', 6', OH3, OH4 
5' 3.61 68.2 dq 9.4, 6.2 4', 6' 1', 3', 4', 6' 3', 4', 6' 
6' 1.26 17.7 d 6.2 5' 4', 5' 4', 5', 7' 
7' 3.44 59.1 s - 
 
2' 2', 6', OH3 
OHa 2.74-2.72 - br s - 21 21,22 
 
OHb 2.40-2.36 - m - 
   
OHc 2.42-2.35 - m - 3' 3' 
 





























1 -- 167.3 - 167.522 -- 166.8 
2 5.92 123.1 6.01 123.1 5.92 123.6 
3 7.02 146.3 6.97 147.1 7.09 146.1 
4a 2.34 38.5 2.36 38.8 2.31 39.5 
4b 2.46 -- 2.39 - 2.39 - 
5 3.42 73.4 3.36 73.9 3.26 73.9 
6a 1.26 36.7 1.20 37.6 1.15 38.2 
6b 1.94 -- 2.02 -- 1.98 - 
7 3.77 72.8 3.82 73.1 3.76 72.7 
8a 1.22 39.3 1.22 39.7 1.27 39.2 
8b 1.84 -- 1.87 -- 1.75 - 
9 3.33 73.1 3.32 72.5 3.16 73.2 
10a 1.27 42.9 1.21 43.1 1.14 43.5 
10b 1.69 -- 1.51 - 1.52 - 
11 2.44 32.8 2.37 34.2 2.48 34.1 
12 5.61 140.9 5.45 141.5 5.32 141.3 
13 6.22 123.8 6.28 123.9 6.10 124.9 
14 6.01 130.5 6.05 131.3 6.00 130.6 
15 5.27 126.5 5.28 126.9 5.20 126.2 
16a 2.14 31.2 1.88 31.1 2.08 31.0 
16b 2.29 -- 2.28 - 2.25 - 
17 4.03 81.3 3.98 81.0 3.99 81.8 
18 2.43 37.1 2.52 37.422 2.46 36.9 
19a 1.28 36.0 1.17 36.8 1.26 36.4 
19b 2.04 -- 2.01 - 2.09 - 
20 3.71 82.7 3.63 83.2 3.74 82.1 
21 3.45 73.4 3.42 73.0 3.46 73.3 
22a 1.54 34.1 1.46 34.1 1.55 34.7 
22b 1.77 -- 1.76 - 1.88 - 
23 5.24 72.5 5.23 72.3 5.23 74.0 
24a 3.65 65.7 3.61 66.1 3.65 65.7 
24b 3.78 -- 3.81 - 3.79 - 
25 1.00 20.1 0.85 18.3 0.98 22.0 
26 0.98 14.7 1.03 14.5 0.98 14.9 
1' 5.02 94.0 5.02 94.2 4.99 94.1 
2' 3.40 80.9 3.40 80.8 3.38 80.9 
3' 3.69 71.7 3.68 71.7 3.68 71.6 
4' 3.34 74.2 3.34 74.3 3.33 74.2 
5' 3.63 68.2 3.62 68.1 3.61 68.2 
6' 1.28 17.7 1.27 17.7 1.26 17.7 
















OH4 2.78-2.64   1.54   2.48-2.44 - 
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  J. Sikorska, Andrew M. Hau, C. Anklin, S. Parker-Nance, M. T. Davies-Coleman, J. E. Ishmael, K. L. 
McPhail, J. Org. Chem. 2012, 77, 6066-6075. 
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  The indicated value was taken from the spectra contained in the SI of Ref. 21 rather than from Table 1 in the 
printed communication, since an error of 0.1 ppm was noticed (for example for C1: 167.47 in the spectra, 
167.4 in the table) 
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Table 5: Comparison of the
 1
H NMR data of 1 and 11-epi-1 with the data of the natural product (NP); 
 = chemical shift differences (in ppm), as indicated.20,21 
atom n° 1 
natural 
product 
11-epi-1  (1NP) 
 (11-epi-1  
NP) 
1 -- - -- -- -- 
2 5.92 6.01 5.92 -0.09 -0.09 
3 7.02 6.97 7.09 0.05 0.12 
4a 2.34 2.36 2.31 -0.02 -0.05 
4b 2.46 2.39 2.39 0.07 0.00 
5 3.42 3.36 3.26 0.06 -0.10 
6a 1.26 1.20 1.15 0.06 -0.05 
6b 1.94 2.02 1.98 -0.08 -0.04 
7 3.77 3.82 3.76 -0.05 -0.06 
8a 1.22 1.22 1.27 0.00 0.05 
8b 1.84 1.87 1.75 -0.03 -0.12 
9 3.33 3.32 3.16 0.01 -0.16 
10a 1.27 1.21 1.14 0.06 -0.07 
10b 1.69 1.51 1.52 0.18 0.01 
11 2.44 2.37 2.48 0.07 0.11 
12 5.61 5.45 5.32 0.16 -0.13 
13 6.22 6.28 6.10 -0.06 -0.18 
14 6.01 6.05 6.00 -0.04 -0.05 
15 5.27 5.28 5.20 -0.01 -0.08 
16a 2.14 1.88 2.08 0.26 0.20 
16b 2.29 2.28 2.25 0.01 -0.03 
17 4.03 3.98 3.99 0.05 0.01 
18 2.43 2.52 2.46 -0.09 -0.06 
19a 1.28 1.17 1.26 0.11 0.09 
19b 2.04 2.01 2.09 0.03 0.08 
20 3.71 3.63 3.74 0.08 0.11 
21 3.45 3.42 3.46 0.03 0.04 
22a 1.54 1.46 1.55 0.08 0.09 
22b 1.77 1.76 1.88 0.01 0.12 
23 5.24 5.23 5.23 0.01 0.00 
24a 3.65 3.61 3.65 0.04 0.04 
24b 3.78 3.81 3.79 -0.03 -0.02 
25 1.00 0.85 0.98 0.15 0.13 
26 0.98 1.03 0.98 -0.05 -0.05 
1' 5.02 5.02 4.99 0.00 -0.03 
2' 3.40 3.40 3.38 0.00 -0.02 
3' 3.69 3.68 3.68 0.01 0.00 
4' 3.34 3.34 3.33 0.00 -0.01 
5' 3.63 3.62 3.61 0.01 -0.01 
6' 1.28 1.27 1.26 0.01 -0.01 
















Diff (1-natural product) Diff (11-epi-1-natural product)
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Table 6: Comparison of the
 13
C data of 1 and 11-epi-1 with the data of the natural product (NP);  = 
chemical shift differences (in ppm), as indicated.
20,21
 
atom n° 1 
natural 
product 
11-epi-1  (1  NP) 
 (11-epi-1  
NP) 
1 167.3 167.5 166.8 -0.2 -0.7 
2 123.1 123.1 123.6 0.0 0.5 
3 146.3 147.1 146.1 -0.8 -1.0 
4 38.5 38.8 39.5 -0.3 0.7 
5 73.4 73.9 73.9 -0.5 0.0 
6 36.7 37.6 38.2 -0.9 0.6 
7 72.8 73.1 72.7 -0.3 -0.4 
8 39.3 39.7 39.2 -0.4 -0.5 
9 73.1 72.5 73.2 0.6 0.7 
10 42.9 43.1 43.5 -0.2 0.4 
11 32.8 34.2 34.1 -1.4 -0.1 
12 140.9 141.5 141.3 -0.6 -0.2 
13 123.8 123.9 124.9 -0.1 1.0 
14 130.5 131.3 130.6 -0.8 -0.7 
15 126.5 126.9 126.2 -0.4 -0.7 
16 31.2 31.1 31.0 0.1 -0.1 
17 81.3 81.0 81.8 0.3 0.8 
18 37.1 37.4 36.9 -0.3 -0.5 
19 36.0 36.8 36.4 -0.8 -0.4 
20 82.7 83.2 82.1 -0.5 -1.1 
21 73.4 73.0 73.3 0.4 0.3 
22 34.1 34.1 34.7 0.0 0.6 
23 72.5 72.3 74.0 0.2 1.7 
24 65.7 66.1 65.7 -0.4 -0.4 
25 20.1 18.3 22.0 1.8 3.7 
26 14.7 14.5 14.9 0.2 0.4 
1' 94.0 94.2 94.1 -0.2 -0.1 
2' 80.9 80.8 80.9 0.1 0.1 
3' 71.7 71.7 71.6 0.0 -0.1 
4' 74.2 74.3 74.2 -0.1 -0.1 
5' 68.2 68.1 68.2 0.1 0.1 
6' 17.7 17.7 17.7 0.0 0.0 


















Diff (1 - natural product) Diff (11-epi-1 - natural product)
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Comparison of the NMR spectra ([D5]-pyridine) of putative Mandelalide A (1, 600 MHz, bottom) with that of the natural product (700 MHz, top)
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The spectra of putative Mandelalide A (1) in CDCl3 (600 MHz) are not strongly concentration dependent:
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